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ABSTRACT 
The European Food Safety Authority (EFSA) was asked to deliver a scientific statement on the increase of risk 
for public health related to a possible temporary derogation from the maximum level (tML) of deoxynivalenol 
(DON), fumonisins (FUMO) and zearalenone (ZON) in maize and maize products. EFSA relied on occurrence 
data reflecting levels of these mycotoxins in the 2013 maize harvest. Depending on the mycotoxin, mean levels 
estimated considering tMLs were increased by a factor comprised between 7.6 and 27 % in maize and maize 
milling  fractions,  and  up  to  99  %  in  some  processed  maize-based  products,  compared  to  levels  estimated 
considering current ML. Chronic exposure levels estimated across the population groups – representing different 
age classes and countries – were increased by a factor up to 17 % for fumonisins, 20 % for deoxynivalenol and 
83 % for zearalenone. The tolerable daily intake (TDI) for zearalenone set by EFSA at 0.25 µg/kg body weight 
(b.w.) per day, and the group provisional maximum tolerable daily intake (PMTDI) of 1 and 2 µg/kg b.w. per 
day  set  by  the  Joint  FAO/WHO  Expert  Committee  on  Food  Additives  (JECFA)  for  deoxynivalenol  and 
fumonisins, were used as chronic health based guidance values (HBGV). For all three mycotoxins these values 
were exceeded in at least one age group when considering the current ML, reflecting a health concern. When 
considering the tMLs, percentages of consumers in the age groups with the highest exposures exceeding chronic 
HBGVs increased from 9.2 to 9.8 % for zearalenone, from 47 to 48 % for fumonisins and from 52 to 54 % for 
deoxynivalenol. Acute exposure scenarios resulted in exceedance of the group acute reference dose (ARfD) of 
8 µg/kg b.w. established by JECFA for DON, with up to 1.2 % of the consumption days above the group ARfD 
with the current ML, and up to 8.1 % with the tML. This assessment, mainly based on French data, may lack 
representativeness for the European situation. 
© European Food Safety Authority, 2014 
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SUMMARY 
Following  a  request  from  the  European  Commission  (EC),  the  European  Food  Safety  Authority 
(EFSA) was asked to deliver a scientific statement on the increase of risk for public health related to a 
possible temporary derogation from the maximum level (ML) of deoxynivalenol (DON), zearalenone 
(ZON) and fumonisins (FUMO) for maize and certain maize products.  
DON is a plant pathogenic mycotoxin, mainly produced by Fusarium graminearum which grows on 
the  crops  in  the  field,  and  occurs  frequently  together  with  its  acetyl-derivatives,  3-acetyl-
deoxynivalenol  (3-Ac-DON)  and  15-acetyl-deoxynivalenol  (15-Ac-DON).  In  2010,  the  Joint 
FAO/WHO Expert Committee on Food Additives (JECFA) established a group provisional maximum 
tolerable daily intake (PMTDI) of 1 µg/kg body weight (b.w.) per day and a group ARfD (acute 
reference dose) of 8 µg/kg b.w. for DON, 3-Ac-DON and 15-Ac-DON which are considered in the 
present assessment.  
FUMO are a group of structurally related plant pathogenic mycotoxins produced mainly by Fusarium 
verticillioides  and  Fusarium  proliferatum  growing  on  cereals,  in  particular  on  maize.  The  group 
PMTDI of 2 µg/kg b.w. per day for fumonisins established in 2011 by JECFA was considered in the 
present assessment. 
ZON is a plant pathogenic mycotoxin produced by different Fusarium species, particularly Fusarium 
graminearum and also Fusarium culmorum, Fusarium equiseti and Fusarium verticillioides, found in 
cereals on the field (in particular maize) but also as a post-harvest contaminant. A tolerable daily 
intake (TDI) of 0.25 µg/kg b.w. per day set by EFSA in 2011 is used for the present assessment.  
Occurrence  data  from  the  2013  harvest  originating  from  three  different  sources  (FranceAgriMer 
collector survey, IRTAC Cereal Sanitary Monitoring Plan, and Euromaisiers) were provided with the 
request. Depending on the source, maize samples were taken at the maize collector and/or at maize 
milling factory. Data were mainly coming from France. DON, ZON and FUMO were analysed with 
enzyme-linked immunosorbent assays (ELISA) and high performance liquid chromatography (HPLC) 
(in  total  2,637  analytical  results).  Occurrence  data  compiled  in  previous  EFSA  and  JECFA  risk 
assessments  were  also  considered.  These  were  mainly  corresponding  to  results  from  official 
monitoring programmes, collected over a 5 - 10 year period between 2000 and 2012, and reported by 
up to 21 European countries (in total 39,202 analytical results).  Mean levels in maize grains and 
maize milling products estimated from the datasets provided with the request appeared to be 1.3 to 
6 times higher compared to mean levels considered in previous assessments.  
The impact of a temporary derogation from the maximum levels was assessed considering the data 
from FranceAgriMer survey which was the most suitable source of information. This represented a 
total of 663 analytical results, 221 results for each mycotoxin. Transfer rates from grain to grain 
milling products were assumed to correspond to the ratio between the temporary derogation from the 
maximum levels (tML) defined in the grain milling products and the tML defined for the unprocessed 
grains.  
Compared to the current MLs, it was estimated that the tMLs would increase mean middle bound 
(MB)  levels  of  DON,  ZON  and  FUMO  in  unprocessed  maize  grains  and  milling  fractions  by 
16 - 18 %, 25 – 27 % and 7.6 – 23 % respectively. Depending on the kind of maize ingredient and its 
percentage content in final processed/composite products, the mean MB levels of DON and FUMO in 
final processed/composite products were increased by 12 – 58 %, whereas mean MB levels of ZON 
were increased by 25 - 99 %. 
Chronic dietary exposure to DON of children age groups estimated with occurrence data reflecting 
current MLs ranged on average between 0.22 and 1.11 µg/kg b.w. per day (minimum lower bound 
(LB) to maximum upper bound (UB)) and at 95
th percentile between 0.94 and 2.10 µg/kg b.w. per day. Maximum levels deoxynivalenol, fumonisins, zearalenone 
 
EFSA Journal 2014;12(5):3699  3 
Chronic dietary exposure to DON of adult age groups ranged on average between 0.18 and 0.56 µg/kg 
b.w. per day and at 95
th percentile between 0.38 and 1.01 µg/kg b.w. per day.  
Depending on the survey and age group, mean and 95
th percentile chronic dietary exposure to DON 
estimated with the occurrence data reflecting tML were up to 20 % higher than the levels estimated 
with the occurrence data reflecting current ML. 
Chronic dietary exposure to ZON of children age groups estimated with occurrence data reflecting 
current MLs ranged on average between 9.7 and 118 ng/kg b.w. per day (minimum LB-maximum UB) 
and at the 95
th percentile between 47 and 303 ng/kg b.w. per day. The chronic dietary exposure to 
ZON of the adult age groups ranged on average between 4.4 and 64 ng/kg b.w. per day and at the 
95
th percentile between 11 and 117 ng/kg b.w. per day. 
Depending on the survey and age group, the mean and 95
th percentile chronic dietary exposure to ZON 
estimated with the occurrence data reflecting tML were up to 83 % higher than the levels estimated 
with the occurrence data reflecting current ML. 
Chronic dietary exposure to FUMO of children age groups estimated with occurrence data reflecting 
current MLs ranged on average between 0.17 and 2.11 µg/kg b.w. per day (minimum LB to maximum 
UB) and at the 95
th percentile between 0.54 and 4.39 µg/kg b.w. per day. Chronic dietary exposure to 
FUMO of adult age groups ranged on average between 0.03 and 1.19 µg/kg b.w. per day and at the 
95
th percentile between 0.08 and 2.30 µg/kg b.w. per day. 
Depending on survey and age group, mean and 95
th percentile chronic dietary exposure to FUMO 
estimated with the occurrence data reflecting tML were up to 17 % higher than the levels estimated 
with the occurrence data reflecting current ML. 
Acute  exposure  scenarios  were  carried  out  for  people  who  consume  maize  grains,  maize  milling 
products,  maize-based  breakfast  cereals,  maize-based  snacks  and  maize-based  pastries  containing 
DON equal to the ML and resulted in a very low percentage of consumption days above the group 
ARfD  (<  1  %)  for  all  products  except  maize-based  pastries,  whatever  the  ML  (current,  tML) 
considered.  For  maize-based  pastries,  percentage  of  consumption  days  above  the  group  ARfD 
estimated up to 1.2 % with current ML was increased up to 8.1 % considering the tML, with a 
maximum acute exposure level estimated at 20.8 µg/kg b.w.  
Exceedance of the group PMTDI for DON is higher in the „children‟ than in the „adults‟ age groups, 
ranging  between  2.7 and  52  %  (minimum  LB  to  maximum  UB)  considering  the  current  MLs. 
Considering the tMLs, this is slightly increased and estimated to range between 4.2 and 54 %. 
The results suggest a low impact of tMLs for chronic exposure levels of DON in all age groups owing 
to the fact that DON exposure is mainly driven by non maize-based foods. However, both application 
of current and increased MLs lead to exposures in the region of the group PMTDI of 1 µg/kg b.w. per 
day especially in the „toddlers‟ age group. 
Percentage of consumption days above the group ARfD of 8 µg/kg b.w. estimated up to 1.2 and 8.1 % 
with  the  current  MLs  and  tMLs,  respectively,  indicates  a  potential  concern  resulting  from  the 
consumption of maize-based pastries containing high DON level for the „children‟ age groups. 
Although the mandate concerns FB1 and FB2, based on the occurrence data available the assessment 
was based on total fumonisin occurrence. Based on the fact that toxicological assessments and also the 
group PMTDI are derived mainly from data with FB1 and the structural similarities of the different 
fumonisin derivatives of relevance, this is considered acceptable.  
The exceedance of the group PMTDI defined for FUMO is higher in the children than in the adults age 
groups, ranging between 0 and 47 % (minimum LB to maximum UB) when considering current ML. Maximum levels deoxynivalenol, fumonisins, zearalenone 
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When considering tML, this is slightly increased and estimated to range between less than 0.1 % and 
48 %. 
Results show that a temporary increase in MLs has only a very minor impact on exposure levels of 
FUMO  and  consequently  on  any  risk  estimates.  However,  when  applying  the  current  MLs,  the 
exposure levels of FUMO are already in the region of the group PMTDI of 2 µg/kg b.w. per day in 
several age groups, being highest in „other children‟ age group.   
Exceedance of the TDI for ZON is the higher in the children than in the adults age groups, ranging 
between 0 and 9.2 % (minimum LB to maximum UB) when considering the current MLs. With tMLs, 
this is slightly increased and estimated to range between 0 and 9.8 %. 
Exposure levels for ZON both with current and tML levels are around or above the TDI of 0.25 µg/kg 
b.w.  per  day  for  the  age  groups  of  „infants‟,  „toddlers‟  and  „other  children‟  and  thus  might  be 
considered as being of health concern. It is important to add here that although no acute reference 
value has been derived for ZON in a previous EFSA assessment, it was pointed out there that is 
possible that elevated circulating levels of oestrogens could lead to adverse effects also from short-
term exposure during a sensitive stage of development. The impact of the increased MLs for ZON 
needs to be considered also in the light of these conclusions.  
It  was  assumed  that  increased  exposure  of  individuals  suffering  from  coeliac  disease  due  to  a 
temporary increase of MLs for DON, FUMO and ZON for maize and maize products were reflected in 
the high exposure levels (95
th percentile) estimated for the general population.  
There is a need to better assess the DON, ZON and FUMO levels in maize grains and maize milling 
products from the 2013 harvest coming from other countries than France and used for food processing 
at the European level. 
   Maximum levels deoxynivalenol, fumonisins, zearalenone 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
Commission Regulation (EC) No 1881/2006 of 19 December 2006
4 lays down maximum levels for 
certain contaminants in foodstuffs, including maximum levels for deoxynivalenol, zearalenone and 
fumonisins.  
On 29 April 2014, the French authorities informed the European Commission that exceptional climatic 
conditions resulted in very high levels of mycotoxins (deoxynivalenol, zearalenone and fumonisins) 
on maize harvested in 2013 in Europe. Furthermore the growing conditions  in the year 2013 resulted 
into  a  higher  carry -over  of  these  mycotoxins  into  the  maize  flours  (while  in  other  years  the 
contamination is more in the outer parts of the maize grain). This results in a serious risk of disruption 
in the maize milling supply chain for the rest of the season (until end of 2014).  
In order to avoid such disruption in the maize milling chain with serious economic consequences, a 
request for a temporary derogation to the mycotoxin regulatory limits has been introduced by the 
French authorities to the Commission. The derogation requested is temporary until the availability of 
the next maize harvest at the end of 2014.  
The  requested  “derogation  values”  compared  to  the  current  maximum  levels  of  deoxynivalenol, 
zearalenone and fumonisins for maize and relevant maize products are provided in the table hereafter. 
Important to note is that no derogation is requested for processed maize-based foods for infants and 
young children and baby foods.  
  Foodstuffs  
Maximum level 
(µg/kg) 
Regulation (EC)  
1881/2006 
Requested temporary 
“derogation value” 
(µg/kg) 
for products produced 
before 31/12/2014 
  Deoxynivalenol
     
1 
Unprocessed  maize,  with  the  exception  of 
unprocessed maize intended to be processed by 
wet milling 
1750
  2250 
2 
Milling  fractions  of  maize  with  particle  size 
> 500 micron falling within CN code 1103 13 or 
1103 20 40 and other maize milling products with 
particle  size  >  500  micron  not  used  for  direct 
human consumption falling within CN code 1904 
1010 
750
  1000 
3 
Milling  fractions  of  maize  with  particle  size 
≤ 500 micron falling within CN code 1102 20 and 
other  maize  milling  products  with  particle  size 
≤ 500  micron  not  used  for  direct  human 
consumption falling within CN code 1904 1010 
1250
  1500 
4  Maize  and  maize  milling  products  intended  for 
direct human consumption   750  1000 
5 
Maize-based  breakfast  cereals  and  maize-based 
snacks,  maize  based  foods  for  direct  human 
consumption  
500  750 
   
                                                       
4 OJ L 364, 20.12.2006, p. 5-17. Maximum levels deoxynivalenol, fumonisins, zearalenone 
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  Foodstuffs  
Maximum level 
(µg/kg) 
Regulation (EC)  
1881/2006 
Requested temporary 
“derogation value” 
(µg/kg) 
for products produced 
before 31/12/2014 
  Zearalenone
     
1 
Unprocessed  maize,  with  the  exception  of 
unprocessed maize intended to be processed by 
wet milling 
350
  500 
2 
Milling  fractions  of  maize  with  particle  size 
> 500 micron falling within CN code 1103 13 or 
1103 20 40 and other maize milling products with 
particle  size  >  500  micron  not  used  for  direct 
human consumption falling within CN code 1904 
1010 
200
  300 
3 
Milling  fractions  of  maize  with  particle  size 
≤ 500 micron falling within CN code 1102 20 and 
other  maize  milling  products  with  particle  size 
≤ 500  micron  not  used  for  direct  human 
consumption falling within CN code 1904 1010 
300
  400 
4 
Maize  intended  for  direct  human  consumption 
and  maize-based  snacks  and  maize  based 
breakfast cereals   
100  200 
5  Maize  milling  products  and  maize  based  foods 
for direct human consumption   100  200 
  Fumonisins B1 + B2
     
1 
Unprocessed  maize,  with  the  exception  of 
unprocessed maize intended to be processed by 
wet milling 
4000
  4500 
2 
Milling  fractions  of  maize  with  particle  size  > 
500 micron falling within CN code 1103 13 or 
1103 20 40 and other maize milling products with 
particle  size  >  500  micron  not  used  for  direct 
human consumption falling within CN code 1904 
1010 
1400
  1900 
3 
Milling  fractions  of  maize  with  particle  size 
≤ 500 micron falling within CN code 1102 20 and 
other  maize  milling  products  with  particle  size 
≤ 500  micron  not  used  for  direct  human 
consumption falling within CN code 1904 1010 
2000
  3500 
4 
Maize  intended  for  direct  human  consumption, 
maize based foods for direct human consumption 
with  the  exception  of  maize-based  breakfast 
cereals and maize-based snacks 
1000  1500 
5  Maize-based  breakfast  cereals  and  maize-based 
snacks  800  1300 
6  Maize milling products intended for direct human 
consumption   1000  1500 
 
 
The request for derogation and the annexes containing information on the extreme weather conditions, 
the difficult harvest conditions and the findings of deoxynivalenol, zearalenone and fumonisins in 
maize of the harvest 2013 are transmitted separately to EFSA.  Maximum levels deoxynivalenol, fumonisins, zearalenone 
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TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION  
In accordance with Art. 31 (1) of Regulation (EC) No 178/2002 the Commission asks EFSA for a 
scientific  statement  assessing  the  possible  increase  of  risk  to  human  health  related  to  a  possible 
temporary derogation of the maximum level of deoxynivalenol, zearalenone and fumonisins for maize 
and maize based products taking into account: 
- the occurrence data provided; 
- the requested derogation values; 
- the specific consumption patterns of maize and maize based foods in the different Member States; 
- the limited time period (until end of 2014) for which the temporary derogation is requested.  
 Maximum levels deoxynivalenol, fumonisins, zearalenone
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ASSESSMENT 
1.  Introduction and previous assessments 
1.1.  Deoxynivalenol 
Deoxynivalenol (DON) is mainly produced by Fusarium graminearum and Fusarium culmorum, plant 
pathogens growing on cereals (wheat, maize, rye, barley, oats, and rice) in temperate climates. It 
frequently  occurs  together  with  its  acetyl-derivatives  (3-acetyl-deoxynivalenol  (3-Ac-DON)  and 
15-acetyl-deoxynivalenol  (15-Ac-DON)  at  levels  of  typically  less  than  10 %  of  those  for  DON 
(FAO/WHO, 2011; Berthiller et al., 2013; Marin et al., 2013; Varga et al., 2013). DON belongs to the 
type B trichothecenes, characterised by a carbonyl group at the C8 position (Döll and Dänicke, 2011). 
The  chemical  structure  of  DON  (12,13-epoxy-3α,7α,15-trihydroxytrichothec-9-en-8-one,  C15H20O6, 
molecular weight: 296.32 g/mol, CAS: 51481-10-8) is shown in Figure 1. DON is usually detected 
with immunoassays, liquid chromatography-mass spectrometry (LC-MS) and liquid chromatography-
tandem mass spectrometry (LC-MS/MS). Among the immunoassays, enzyme-linked immunosorbent 
assays  (ELISA)  are  widely  used  but  have  the  disadvantage  of  cross-reactivity  and  false-positive 
results, thus, positive results are usually confirmed by other analytical methods (Ran et al., 2013). 
 
 
 
 
 
 
 
 
 
Figure 1:  Chemical structure of deoxynivalenol 
Earlier risk assessments for DON are available from the Scientific Committee on Food (SCF, 1999) in 
which a temporary tolerable daily intake (tTDI) of 1 µg/kg body weight (b.w.) per day has been set 
based on a no-observed-adverse-effect level (NOAEL) for reduced growth in a chronic mouse study 
(UF 100) which was confirmed as a tolerable daily intake (TDI) in a later opinion SCF (2002). JECFA 
(FAO/WHO,  2002)  further  confirmed  this  health  based  guidance  value  (HBGV)  by  setting  a 
provisional maximum tolerable daily intake (PMTDI) of 1 µg/kg b.w. per day.  
The most recent comprehensive risk assessment on deoxynivalenol in food has been carried out by 
JECFA  (FAO/WHO,  2011).  The  EFSA  Scientific  Panel  on  Contaminants  in  the  Food  Chain 
(CONTAM Panel) has issued a statement (EFSA CONTAM Panel, 2013) in regard to the risks related 
to a possible increase of the maximum levels for DON in certain cereal products which was based on 
the toxicological assessment carried out by JECFA earlier on. In July 2013, EFSA received a request 
from the European Commission to deliver a scientific opinion on the risks for animal and public health 
related to the presence of DON, metabolites of DON and masked DON in food and feed. As the 
deadline for finalisation of this risk assessment is later than that for the present request, EFSA used the 
HBGVs as established by JECFA (FAO/WHO, 2011) also for the present assessment. It needs to be 
pointed out here that since the present assessment is triggered by an urgent request from the European 
Commission for a temporary derogation from the legally binding MLs for some certain foodstuffs and 
does not constitute a comprehensive risk assessment it cannot anticipate or overrule any outcome of 
the risk assessment of DON in food and feed to be issued at a later point in time.  Maximum levels deoxynivalenol, fumonisins, zearalenone 
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In their evaluation JECFA (FAO/WHO, 2011) reported that DON and its acetyl derivatives are rapidly 
and extensively absorbed from the gastrointestinal tract and the main part is also rapidly excreted 
mainly via the urine. Adverse effects of DON occurring already after single dose application are 
decreased feed consumption and emesis. DON does not exert mutagenic potential in bacteria while 
there is ambiguous evidence for its clastogenicity. DON is considered as being devoid of carcinogenic 
potential. A NOAEL for developmental effects of 2.5 mg/kg b.w. per day based on an increase in 
misaligned  and  fused  sternaebrae  at  5  mg/kg  b.w.  per  day  in  pups  was  derived  from  a  rat 
developmental  study  (Collins  et  al.,  2006).  In  a  reproductive  study  with  male  rats  a  NOAEL  of 
1 mg/kg b.w. per day was derived based on reduced epididymal and seminal vesicle and increased 
sperm  motility  (Sprando  et  al.,  2005).  Low  doses  of  DON  have  immunological  effects  (i.e.  they 
increased  immunoglobuline  A  levels  in  blood  of  mice  and  pigs).  And  the  mechanistic  evidence 
obtained from these species  indicate that immunological effects and the reduced weight gain  from 
which the PMTDI was derived were mainly due to suppression of cytokine signalling and interference 
with pituitary growth hormone (GH) axis. Changes in these parameters occurred early in studies and 
were rapidly reversible and it was concluded that at dietary exposure levels only continuous exposure 
would lead to the observed effects on the immune system and growth.  
Taking into account the overall toxicological evidence a PMTDI of 1 µg/kg b.w. per day was derived 
on basis of a no-observed-effect level (NOEL) of 100 µg/kg b.w. per day for reduced growth observed 
in a 2- year feeding study in mice applying an uncertainty factor (UF) of 100 for inter- and intra-
species differences. Since 3-Ac-DON is transformed to DON and thus contributing also to its toxicity, 
the  Committee  concluded  further  to  convert  the  PMTDI  to  a  group  PMTDI  for  DON,  and  its 
acetylated derivatives 3-Ac-DON and 15-Ac-DON.  
A group acute reference dose (ARfD) for the sum of DON, 3-Ac-DON and 15-Ac-DON of 8 µg/kg 
b.w. was established in addition as an acute reference point based on the lower 95 % confidence limit 
for a benchmark response of 10 % extra risk (BMDL10) of 0.21 mg/kg b.w. per day, based on emesis 
observed in pigs and by applying an uncertainty factor of 25. 
1.2.  Fumonisins 
Fumonisins  are  a  group  of  structurally  related  mycotoxins  produced  mainly  by  Fusarium 
verticillioides and F. proliferatum, plant pathogens growing on cereals in particular on maize. The  B 
series of fumonisins, including FB1, FB2, FB3 and FB4, is the most frequently occurring form in food, 
the FB1 derivative being the form for which most biological and occurrence data is available. The 
toxicological properties of the FB2 and FB3 derivatives are very similar (FAO/WHO, 2002, 2012). The 
chemical structure of Fumonisin B1 (the diester of propane-1,2,3-tricarboxylic acid and 2S-amino-
12S,16R-dimethyl-3S,5R,10R,14S,15R-pentahydroxyeicosane  in  which  the  C-14  and  C-15  hydroxy 
groups  are  esterified  with  the  terminal  carboxy  group  of  propane-1,2,3-tricarboxylic  acid,  CAS: 
116355-83-0) is shown in Figure 2. Fumonisins (FB1, FB2, FB3) are usually determined in food via 
liquid chromatography with fluorescence detection. Other methods are liquid chromatography coupled 
with mass spectrometry.  Immunoassays are also employed but results have to be confirmed with 
quantitative methods (FAO/WHO, 2012). Maximum levels deoxynivalenol, fumonisins, zearalenone 
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Figure 2:  Chemical structure of fumonisin B1 
Earlier assessments for FUMO are available from the SCF (2000a) where a TDI of 2 µg/kg b.w. per 
day for FB1 based on kidney effects was derived. In an updated opinion (SCF, 2003) they concluded 
that the TDI for FB1 could be extended to a group TDI for the total fumonisin B1, B2 and B3 alone or 
combined. Likewise the JECFA (FAO/WHO, 2002) derived a group PMTDI for fumonisins B1, B2 
and B3 alone or in combination. 
The most recent comprehensive risk assessment related to the presence of fumonisins in food has been 
presented by the JECFA (FAO/WHO, 2012) and the health based guidance value (HBGV) established 
therein are consequently also used as a basis for the present assessment. As for DON it has to be noted 
here that the present assessment is based on an urgent request from the Commission and thus does not 
constitute a comprehensive risk assessment and likewise cannot anticipate any future in depth analyses 
on fumonisins that might be carried out by EFSA.  
As the previous assessments, the recent JECFA evaluation (FAO/WHO, 2012) is essentially based on 
data  generated  with  FB1  which  is  owing  to  the  scarcity  of  information  on  the  other  fumonisin 
derivatives. Fumonisins are poorly absorbed from the digestive tract (main residues are found in liver 
and  kidney),  rapidly  distributed  and  eliminated  mainly  unchanged.  Fumonisins  do  not  exert 
appreciable acute toxicity. Kidney and liver are the organs most sensitive towards fumonisin mediated 
toxicity in rats and mice. Early signs of fumonisin nephrotoxicity are increased free sphingoid bases in 
plasma and urine, apoptosis and cell regeneration in renal tubule cells, while early hepatotoxicity 
manifests as apoptotic and oncotic necrosis, cell proliferation, hyperplasia and bile duct regeneration. 
Mechanistic  studies  suggest  disruption  of  lipid  metabolism  as  being  the  mode  of  action  for  FB1 
mediated toxicity. FB1 is not mutagenic but is capable of inducing reactive oxygen species that could 
lead to DNA damage. FB1 caused effects in some developmental and reproductive studies (induction 
of  neural  tube  defects  in  mice  and  decreased  reproductive  performance  in  rabbits  and  pigs 
respectively).  However,  JECFA  concluded  not  to  consider  these  studies  as  their  significance  and 
validity were considered as being doubtful.   
NOAELs for FB1 of 0.67 mg/kg b.w. per day and 0.8 mg/kg b.w. day for induction of kidney tumours 
in rats and liver tumours in mice have been reported. It was noted by JECFA that taking into account 
mechanistic information, together with the overall toxicological data, it could be hypothesized that the 
perturbation of lipid metabolism induced by FB1 causes cell death possibly via oxidative damage,  
regenerative cell proliferation, which could lead to the increase in kidney and liver tumours.  
Taking into account the overall evidence available, a group PMTDI of 2 µg/kg b.w. per day based on a 
BMDL10 of 165 µg/kg b.w. per day for increased incidence of megalocytic hepatocytes observed in a 
chronic  mouse  study  mice  was  derived  adding  an  UF  of  100  for  interspecies  and  intra-species 
differences.  Maximum levels deoxynivalenol, fumonisins, zearalenone
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1.3.  Zearalenone 
Zearalenone  (ZON)  is  a  mycotoxin  produced  by  different  Fusarium  species,  particularly 
F. graminearum and also F. culmorum, F.equiseti and F. verticillioides, plant pathogens found in 
cereals on the field such as wheat, barley, sorghum and rye, and in particular in maize in moist and 
cool  weather  but  it  may  also  occur  as  a  post-harvest  contaminant.  The  chemical  structure  of 
zearalenone (3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-
1,7(8H)-dione; C18H22O5; molecular weight: 318.36; CAS No: 17924-92-4) is depicted in Figure 3. 
ZON is detected with a wide variety of analytical methods coupling of HPLC and MS being the most 
commonly used technique (EFSA CONTAM Panel, 2011).  
 
     
Figure 3:  Chemical structure of zearalenone 
 
Earlier assessments are available from JECFA (FAO/WHO, 2000b) who established a PMTDI of 
0.5  g/kg b.w. per day for ZON and its metabolite α-zearalanol based on oestrogenic effects seen in 
pigs. Likewise the SCF (SCF, 2000b) used the NOEL from this study but applied a higher safety 
factor to derive a temporary TDI (tTDI) of 0.2  g/kg b.w. per day.  
The most recent comprehensive risk assessment available for zearalenone which is serving as a basis 
for the present evaluation is a scientific opinion on the risks for public health related to the presence of 
zearalenone in food issued by EFSA (EFSA CONTAM Panel, 2011). Zearalenone is readily absorbed 
through the gastrointestinal tract and extensively metabolised and distributed to various tissues (Shin 
et al., 2009). It is of low acute toxicity (oral LD50 values are above 2000 mg/kg b.w.). Zearalenone is 
not mutagenic in bacteria but exerts in vivo clastogenicity in mice. Zearalenone is not tumorigenic in 
rats but caused a statistically significant increase in benign liver tumours in female mice at doses as 
high as 18 mg/kg b.w. per day (NTP, 1982). Zearalenone exerts haematological- and liver changes in 
subchronic and chronic animal tests. Zearalenone also adversely affects testosterone synthesis, sexual 
behaviour, sex organ weights, testicular histology and spermatogenesis in male animals. In female 
animals the reproductive tract, fertility an embryo survival are adversely affected. The female pig is 
particularly sensitive towards the oestrogenic effects of zearalenone (respective effects occur at doses 
around three  orders  of  magnitude lower than those  causing  clastogenicity  or  adenomas  described 
above). 
Therefore the CONTAM Panel established a TDI of 0.25 µg/kg b.w. per day which was derived from 
a  NOEL  of  10  µg/kg  b.w.  per  day  for  oestrogenic effects  from  a  repeated  dose  study  with  gilts 
(Edwards et al., 1987). An uncertainty factor of 40 was applied to account for inter- and intra-species 
differences.  Maximum levels deoxynivalenol, fumonisins, zearalenone 
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2.  Legislation on fumonisins, deoxynivalenol and zearalenone in food
5  
Article 2 of Council Regulation (EEC) No 315/98
6 stipulates that food containing contaminants in 
amounts not acceptable from a public health viewpoint shall not be placed on the market. In addition 
contaminant levels shall be kept as low as possible. In order to protect public health maximum  levels 
(ML) for specific contaminants in different foodstuffs have been laid down in Commission Regulation 
(EC) No 1881/2006
7. The MLs established for  deoxynivalenol, fumonisins and zearalenone and as 
listed in the Regulation are presented in Tables 1- 3. 
Table 1:  Maximum  levels  in  µg/kg  for  deoxynivalenol  in  various  foodstuffs  as  laid  down  in 
Commission Regulation (EC) No 1881/2006  
Category  Foodstuff
  ML 
1  Unprocessed cereals
(a,b) other than durum wheat, oats and maize  1250 
2  Unprocessed durum wheat and oats
(a,b)  1750 
3  Unprocessed maize
(a), with the exception of unprocessed maize intended to be 
processed by wet milling
(c) 
1750
 
4  Cereals intended for direct human consumption, cereal flour, bran and germ as 
end  product  marketed  for  direct  human  consumption,  with  the  exception  of 
foodstuffs listed in 7, 8 and 9 
750 
5  Pasta (dry)
(d)  750 
6  Bread  (including  small  bakery  wares),  pastries,  biscuits,  cereal  snacks  and 
breakfast cereals 
500 
7  Processed cereal-based foods and baby foods for infants and young children
(e,f)  200 
8  Milling fractions of maize with particle size > 500 micron falling within CN code 
1103 13 or 1103 20 40 and other maize milling products with particle size > 500 
micron  not  used  for  direct  human  consumption  falling  within  CN  code  1904 
1010 
750 
9  Milling fractions of maize with particle size ≤ 500 micron falling within CN code 
1102 20 and other maize milling products with particle size ≤ 500 micron not 
used for direct human consumption falling within CN code 1904 1010 
1250 
CN: combined nomenclature; ML: maximum level. 
(a):
   The  maximum  level  applies  to  unprocessed  cereals  placed  on  the  market  for  first-stage  processing.  „First-stage 
processing‟ shall mean any physical or thermal treatment, other than drying, of or on the grain. Cleaning, sorting and 
drying procedures are not considered to be „first-stage processing‟ insofar no physical action is exerted on the grain 
kernel itself and the whole grain remains intact after cleaning and sorting. In integrated production and processing 
systems, the maximum level applies to the unprocessed cereals in case they are intended for first-stage processing.  
(b):
  The maximum level applies to cereals harvested and taken over, as from the 2005/06 marketing year, in accordance with 
Commission Regulation (EC) No 824/2000 of 19 April 2000 establishing procedures for the taking-over of cereals by 
intervention agencies and laying down methods of analysis for determining the quality of cereals (OJ L 100, 20.4.2000, 
p. 31), as last amended by Regulation (EC) No 1068/2005 (OJ L 174, 7.7.2005, p. 65). 
(c):  The exemption applies only for maize for which it is evident e.g. through labelling, destination, that it is intended for use 
in a wet milling process only (starch production). 
(d):
  Pasta (dry) means pasta with a water content of approximately 12 %. 
(e):
   Foodstuffs listed in this category as defined in Commission Directive 2006/125/EC of 5 December 2006 on processed 
cereal-based foods and baby foods for infants and young children (OJ L 339, 6.12.2006, p. 16). 
(f):
   The maximum level refers to the dry matter. The dry matter is determined in accordance with Regulation (EC) No 
401/2006. 
 
   
                                                       
5  In this scientific statement, where reference is made to European legislation, the reference should be understood as relating 
to the most current amendment, unless otherwise stated. 
6  Council Regulation (EEC) No 315/93 of February 1993 laying down Community procedures for contaminants in food. 
OJ L 37, 13.2.1993, p. 1-5. 
7  Commission Regulation (EC) No 1881/2006 of 19 December 2006 setting maximum levels for certain contaminants 
in food. OJ L 364, 20.12.2006, p. 5-24. Maximum levels deoxynivalenol, fumonisins, zearalenone 
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Table 2:  Maximum  levels  in  µg/kg  for  fumonisins  in  various  foodstuffs  as  laid  down  in 
Commission Regulation (EC) No 1881/2006 
Category  Foodstuff
  ML 
1  Unprocessed  maize
(a),  with  the  exception  of  unprocessed  maize  intended  to  be 
processed by wet milling
(b) 
4000 
2  Maize  intended  for  direct  human  consumption,  maize-based  foods  for  direct 
human consumption, with the exception of foodstuffs listed in 3 and 4
 
1000 
3  Maize-based breakfast cereals and maize-based snacks  800
 
4  Processed maize-based foods and baby foods for infants and young children 
(c,d)  200 
5  Milling fractions of maize with particle size > 500 micron falling within CN 
code 1103 13 or 1103 20 40 and other maize milling products with particle size 
> 500 micron not used for direct human consumption falling within CN code 
1904 10 10 
1400 
6  Milling fractions of maize with particle size ≤ 500 micron falling within CN 
code 1102 20 and other maize milling products with particle size ≤ 500 micron 
not used for direct human consumption falling within CN code 1904 10 10 
2000 
CN: combined nomenclature; ML: maximum level. 
 (a): The  maximum  level  applies  to  unprocessed  cereals  placed  on  the  market  for  first-stage  processing.  „First-stage 
processing‟ shall mean any physical or thermal treatment, other than drying, of or on the grain. Cleaning, sorting and 
drying procedures are not considered to be „first-stage processing‟ insofar no physical action is exerted on the grain 
kernel itself and the whole grain remains intact after cleaning and sorting. In integrated production and processing 
systems, the maximum level applies to the unprocessed cereals in case they are intended for first-stage processing. 
(b):  The exemption applies only for maize for which it is evident, e.g. through labelling, destination, that it is intended for 
use in a wet milling process only (starch production).‟ 
(c):  Foodstuffs listed in this category as defined in Commission Directive 96/5/EC of 16 February 1996 on processed cereal-
based foods and baby foods for infants and young children (OJ L 49, 28.2.1996, p. 17) as last amended by Directive 
2003/13/EC (OJ L 41, 14.2.2003, p. 33). 
(d):  The maximum level refers to the dry matter. The dry matter is determined in accordance with Regulation (EC) No 
401/2006. 
   Maximum levels deoxynivalenol, fumonisins, zearalenone 
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Table 3:  Maximum  levels  in  µg/kg  for  zearalenone  in  various  foodstuffs  as  laid  down  in 
Commission Regulation (EC) No 1881/2006  
Category  Foodstuff
  ML 
1  Unprocessed cereals other than maize  100 
2  Unprocessed  maize  with  the  exception  of  unprocessed  maize  intended  to  be 
processed by wet milling
(a) 
350 
3  Cereals intended for direct human consumption, cereal flour, bran and germ as end 
product marketed for direct human consumption, with the exception of foodstuffs 
listed below in 6, 7, 8, 9 and 10 
75
 
4  Refined maize oil  400 
5  Bread  (including  small  bakery  wares),  pastries,  biscuits,  cereal  snacks  and 
breakfast cereals, excluding maize snacks and maize based breakfast cereals 
50 
6  Maize intended for direct human consumption, maize-based snacks and  maize-
based breakfast cereals 
100 
7  Processed cereal-based foods (excluding processed maize-based foods) and baby 
foods for infants and young children
(b,c) 
20 
8  Processed maize-based foods for infants and young children
(b,c)  20 
9  Milling fractions of maize with particle size >500 micron falling within CN code 
1103 13 or 1103 20 40 and other maize milling products with particle size >500 
micron not used for direct human consumption falling within CN code 1904 10 10 
200 
10  Milling fractions of maize with particles size <500 micron falling within CN code 
1102 20 and other maize milling products with particle size <500 micron not used 
for direct human consumption falling within CN code 1904 10 10 
300 
ML: maximum level; CN: combined nomenclature. 
(a):  The exemption applies only for maize for which it is evident e.g. through labelling, destination, that it is intended for 
use in a wet milling process only (starch production). 
(b):  The maximum levels refer to dry matter. 
(c):    Foodstuffs listed in this category as defined in Commission Directive 96/5/EC of 16 February 1996 on processed cereal 
based foods and baby foods for infants and young children (OJ L 49, 28.2.1996, p. 17-28) as last amended by Directive 
2003/13/EC (OJ L 41, 14.2.2003, p. 33-36.) 
3.  Occurrence data  
3.1.  Overview of the data available for the analysis 
3.1.1.  Data provided with the request 
Individual occurrence data considered in this statement were received from three different sources: the 
FranceAgriMer collector survey, the IRTAC Cereal Sanitary Monitoring Plan and Euromaisiers. 
  Data from FranceAgriMer collector survey 
This survey provides a representative overview of DON, ZON and FUMO levels in the 2013 French 
maize grain harvest. Maize grains samples were taken at the collecting site. For each collecting site 
surveyed, three samples were taken after drying, one at the beginning of the collection, one at the 
middle and one at the end. The three samples were then pooled into one composite sample and crushed 
into  particle  size  below  500  µm.  A  total  of  221  composite  samples  were  constituted. They  were 
analysed  for  ZON,  DON  and  FUMO  using  enzyme  immunoassay  kits  (ELISA)  with  a  limit  of 
quantification (LOQ) of 25 µg/kg for ZON and 222 µg/kg for DON and FUMO, respectively. When 
levels were respectively above 225, 1400 and 2800 µg/kg, results were confirmed with an analytical 
method based on liquid chromatography with UV detection for DON and fluorescence detection for 
ZON and FUMO. The dataset contained 663 analytical results (221 for DON, 221 for FUMO, 221 for 
ZON). Maximum levels deoxynivalenol, fumonisins, zearalenone 
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  Data from IRTAC Cereal Sanitary Monitoring Plan 
This monitoring plan integrates the results of self-checks realised by different operators of the French 
cereal  sector  (maize  collectors  and  maize  milling  factories),  which  may  not  be  representative  of 
French maize production and collection. DON, ZON and FUMO were analysed by ELISA and high 
performance liquid chromatography (HPLC). The limit of detection (LOD) for the ELISA was at 
25 µg/kg for ZON, at 100 µg/kg for FUMO and ranging from 100 to 250 µg/kg for DON. The LOQ 
for HPLC was at 20 µg/kg for FUMO, at 50 µg/kg for DON and ranging from 10 to 50 µg/kg for 
ZON. When, for a given sample, results were available for both ELISA and HPLC, only the result 
generated  by  HPLC  was  further  considered.  When  several  results  were  available  for  the  same 
mycotoxin  in  a  given  sample,  the  average  was  estimated  and  considered  as  the  indicator  of  the 
corresponding mycotoxin level in that sample. The final adjusted dataset contained 956 results (451 
for DON, 175 for FUMO, 330 for ZON) covering the first part of the 2013/2014 campaign. 
  Data from Euromaisiers 
Euromaisiers provided a compilation of DON, ZON and FUMO levels found in maize received by 
milling factories, i.e. after a pre-selection of the grains by the suppliers, and in maize milling products. 
The data were provided by factories located in several European countries (Germany, Belgium, Spain, 
France, Hungary, Italy, Poland and the UK). The maize grains analysed were not only coming from 
France, but also from other European countries (detailed list not communicated) and from outside the 
Europe Union (EU) (Argentina, Serbia, Russia, Ukraine, Turkey). The maize milling products were 
prepared and analysed after the exclusion of non compliant grains. The analytical techniques and 
limits of detection/quantification were not systematically reported. From the reported data:  
-  DON was indicated to be analysed with ELISA, strip test and HPLC, with LOQ ranging from 
10 to 500 µg/kg; 
-  ZON was indicated to be analysed with ELISA and HPLC, with LOQ ranging from less than 
2 to 50 µg/kg; 
-  FUMO was indicated to be analysed with ELISA and HPLC, with LOQ ranging from 15 to 
500 µg/kg. 
The  dataset  contained  1,018  analytical  results  (387  for  DON,  453  for  FUMO,  178  for  ZON) 
corresponding to samples taken between November 2013 to March 2014, out of which 16 % were 
indicated to correspond to maize grains coming from outside EU. 
  Considerations on data quality and comparability 
Due to the short deadline of the Commission request, EFSA used the results as received, without 
applying any quality criteria. It is underlined  that the results originating from different analytical 
techniques (ELISA and HPLC) may not be strictly comparable. Indeed, whereas HPLC technique is 
generally  capable  of  differentiating  between  the  parent  compound  DON  and  its  derivatives  and 
conjugates,  ELISA  based  methods  cover  also  the  derivatives  and  conjugates  and  even  other 
mycotoxins due to the cross-reactivity of the antibodies (EFSA CONTAM Panel, 2013). Regarding 
FUMO, results from ELISA were indicated to correspond to the sum of fumonisins B1, B2 and B3 
whereas the results from HPLC corresponded to the sum of fumonisins B1 and B2 only. As done in the 
JECFA evaluation (FAO/WHO, 2012), the results corresponding to the sum of fumonisins B1 and B2 
were used together with the ones corresponding to the sum of fumonisins B1, B2 and B3, without any 
adjustment. Maximum levels deoxynivalenol, fumonisins, zearalenone 
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3.1.2.  Data used in previous risk assessments  
For  this  statement,  EFSA  also relied  on  occurrence  data  collated in  the  framework  of  the  EFSA 
continuous data call
8 that were compiled in the framework of previous assessments.  
The DON dataset was the one used in the statement of the  CONTAM Panel on the risks  for public 
health related to a possible increase of the maximum level of  deoxynivalenol  for certain semi-
processed cereal products (EFSA CONTAM Panel, 2013). The dataset contained 10 ,757 analytical 
results on the DON parent compound, that were generated with analytical methods based on gas or 
liquid chromatography, obtained on food samples collected between 2007 and 2012 and reported by 
21  European  countries.   Regarding  „Unprocessed  grains‟,  data  corresponded  to  those  that  were 
compiled in the EFSA report on deoxynivalenol in food and feed: occurrence and exposure (EFSA, 
2013). The dataset contained 975 analytical results, generated with analytical methods based on gas or 
liquid chromatography and ELISA, collected between 2007 and 2012 and reported by 12 European 
countries. 
The ZON dataset was the one used in the scientific opinion of the CONTAM Panel on the risks for 
public health related to the presence of zearalenone in food (EFSA CONTAM Panel, 2011). The 
dataset  contained  13,075  analytical  results  obtained  on  food  samples  and  9,877  results  on 
„Unprocessed  grains‟  samples,  generated  with  analytical  methods  based  on  gas  or  liquid 
chromatography  and  ELISA,  collected  between  2005  and  2010  and  reported  by  19  European 
countries.  
The FUMO dataset corresponded to the European data that were considered by the JECFA in its risk 
assessment  (FAO/WHO,  2012).  The  dataset  contained  3,654  analytical  results  obtained  on  food 
samples and 864 results on „Unprocessed grains‟ samples, generated with analytical methods based on 
gas  or  liquid  chromatography  and  ELISA,  collected  between  2000  and  2010  and  reported  by 
11 European countries. Around 44 % of the analytical results corresponded to the sum of fumonisins 
B1, B2 and B3 whereas the other results corresponded to the sum of fumonisins B1 and B2 only. All 
these results were used together without any adjustment.  
 
3.2.  Description of occurrence levels 
3.2.1.  Levels of DON, ZON and FUMO in maize grains and maize milling products  
Table 4 presents DON, FUMO and ZON levels estimated from different sources: the data used in 
previous assessments, the FranceAgriMer survey, the IRTAC monitoring plan and the Euromaisiers 
data. Three estimates were produced depending on the assessment made on the results below the 
LOD/LOQ: (i) the lower bound estimate (LB), replacing all results reported as below the LOD/LOQ 
by 0, (ii) the middle bound estimate (MB), replacing all results reported as below the LOD/LOQ by 
half their respective LOD/LOQ and (iii) the upper bound estimate (UB), replacing all results reported 
as below the LOD/LOQ to their respective LOD/LOQ. Mean and 95
th percentile of the three estimates 
(LB, MB and UB) were then computed.  
For comparison purposes with the other sources of data, results of the FranceAgriMer survey which 
were above the ML were not considered when producing the descriptive statistics. In order to get 
representative  estimates  of  DON,  FUMO  and  ZON  levels  found  in  the  2013  French  harvest, 
descriptive  statistics  from  the  FranceAgriMer  survey  were  weighted  by  means  of  information, 
available for each sample, related to the production of maize grains at national level. 
Data from previous assessments were described according to FoodEx1 classification system for food, 
which does not include information on the particle size of maize milling fractions. By default, maize 
                                                       
8 http://www.efsa.europa.eu/en/data/call/datex101217.htm  Maximum levels deoxynivalenol, fumonisins, zearalenone 
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flour, maize meal and maize starch were considered as „Maize milling fractions with particle size 
≤ 500 µm‟ whereas maize semolina was considered as „Maize milling fractions with particle size 
> 500 µm‟. 
The mean levels of DON in unprocessed maize grains and maize milling fractions estimated from the 
FranceAgriMer survey, IRTAC monitoring plan and Euromaisiers data are found to be from 3 up to 
6 times higher than the mean levels estimated over a five years period (2007 – 2012) in the previous 
assessment (EFSA CONTAM Panel, 2013). The mean level of DON estimated from Euromaisiers 
data appears to be 2 times higher than the mean level estimated from the FranceAgriMer survey, 
which may reflect differences between levels in the 2013 French maize grain harvest and levels in 
maize grains used for food processing at the European level. 
The mean levels of ZON in unprocessed maize grains as estimated from the FranceAgriMer survey 
and IRTAC monitoring plan are 2 – 2.5 times higher than the mean levels estimated over a five years 
period  (2005  –  2010)  in  the  previous  risk  assessment  (EFSA  CONTAM  Panel,  2011).  However, 
results  from  Euromaisiers  in  unprocessed  grains  are  in  the  same  ranges  as  the  ones  previously 
reported. The mean levels of ZON in milling fractions estimated from the Euromaisiers data are from 
1.3 up to 4 times higher than the mean levels. 
The mean levels of FUMO in unprocessed maize grains as estimated from the Euromaisiers survey are 
twice as high as the mean levels estimated over a ten years period (2000 – 2010) in the previous risk 
assessment  (FAO/WHO,  2012).  However,  results  from  the  FranceAgriMer  survey  and  IRTAC 
monitoring are below the mean levels. The mean levels of FUMO in maize milling fractions are from 
2 to 5.6 times higher than the mean background levels. 
In conclusion, it appears that levels of DON, ZON and FUMO in the maize grains and grain milling 
products as observed in the FranceAgriMer survey, the IRTAC monitoring plan and Euromaisiers data 
are 1.3 to 6 times higher compared to mean levels considered in previous assessments. Euromaisiers 
data indicate higher DON and FUMO levels and lower ZON levels than the FranceAgriMer survey 
and IRTAC monitoring plan. This may reflect differences between DON, ZON and FUMO levels in 
the  2013  French  maize  grain  harvest  and  levels  in  maize  grains  used  for  food  processing  at  the 
European level, which are not only coming from France but also from other European countries and 
from outside EU. All these observations have to be interpreted cautiously considering discrepancies 
regarding  the  compounds  covered  by  the  different  analytical  methods  (ELISA  vs.  liquid  and  gas 
chromatography) present in each source of data. 
 
Table 4:  DON, FUMO and ZON levels in maize grains and maize milling products in µg/kg  
Crop/food group  Source   N  Mean  
MB [LB – UB]
(a) 
P95  
MB [LB – UB]
 (a,b) 
DON 
Unprocessed maize grains  EFSA, 2013  246  318 [286; 350]  1367 
Unprocessed maize grains  FranceAgriMer   166  996 [993; 1000]  1674 
Unprocessed maize grains  IRTAC plan  451  1145 [1139; 1150]  2760 
Unprocessed maize grains  Euromaisiers  147  1840 [1839; 1841]  15000 
Maize milling fractions > 500 µm  EFSA CONTAM 
Panel, 2013  38  96 [79; 113]  - 
Maize milling fractions > 500 µm  Euromaisiers  156  275  841 
Maize milling fractions ≤ 500 µm  EFSA CONTAM 
Panel, 2013  133  106 [80; 131]  402 
Maize milling fractions ≤ 500 µm  Euromaisiers  84  386  1117 
   Maximum levels deoxynivalenol, fumonisins, zearalenone 
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Table 4:   Continued 
Crop/food group  Source   N  Mean  
MB [LB – UB]
(a) 
P95  
MB [LB – UB]
 (a,b) 
FUMO 
Unprocessed maize grains  FAO/WHO, 2012  862  1035 [974; 1096]  4642 
Unprocessed maize grains  FranceAgriMer  199  617 [564; 673]  2298 
Unprocessed maize grains  IRTAC plan  175  325 [307; 344]  1900.7 
Unprocessed maize grains  Euromaisiers  281  2771  15000 
Maize milling fractions > 500 µm  FAO/WHO, 2012  535  230 [216; 243]  1064 
Maize milling fractions > 500 µm  Euromaisiers  122  497  1674 
Maize milling fractions ≤ 500 µm  FAO/WHO, 2012  549  471 [456; 486.2]  2288 
Maize milling fractions ≤ 500 µm  Euromaisier  50  2672  -b 
ZON 
Unprocessed maize grains  EFSA CONTAM 
Panel, 2011  2460  [76; 87]  319 
Unprocessed maize grains  FranceAgriMer  157  167 [166; 167]  327 
Unprocessed maize grains  IRTAC plan  330  192 [191; 193]  493 
Unprocessed maize grains  Euromaisiers  65  51  297 
Maize milling fractions > 500 µm  EFSA CONTAM 
Panel, 2011  351  [5; 7]  [22; 23] 
Maize milling fractions > 500 µm  Euromaisiers  101  27  49 
Maize milling fractions ≤ 500 µm  EFSA CONTAM 
Panel, 2011  382  [20; 22]  [73; 78] 
Maize milling fractions ≤ 500 µm  Euromaisiers  12  30  - 
N: number of samples; P95: 95
th percentile; MB/LB/UB: middle bound/lower bound/upper bound estimates.  
(a):  When the MB, LB and UB estimates are equal, only one estimate is given.  
(b):  95
th percentile is only reported for food groups for which at least 60 samples were available. 
Note: the occurrence values are rounded at the level of the microgram, however this does not reflect precision.  
 
3.2.2.  Levels of DON, ZON and FUMO in other foods  
The LB and UB mean DON, ZON and FUMO levels in foods other than maize grains and maize-
based products that were compiled in previous assessments are provided in Appendix A. DON, ZON 
and FUMO are mainly found in grains, grain-based products (grain milling products, bread, breakfast 
cereals, pasta, fine bakery wares) and other foods containing cereals (cereal-based dishes, cereal-based 
foods for infants and young children, snacks, products for special nutritional use). Depending on the 
grain and grain-based products, mean UB levels are comprised between 15.5 and 410 µg/kg for DON, 
3.0 and 33 µg/kg for ZON, 37.4 and 315 µg/kg for FUMO. Overall, the highest average levels are 
observed in wheat or wheat milling products. DON, ZON and FUMO are also found in sweet corn 
with mean UB levels at respectively 53.2, 4.8 and 102 µg/kg. Finally, ZON is occurring in oils made 
from corn and wheat germ, with LB – UB mean levels comprised between 31 and 90 µg/kg, and in 
beer and beer-like beverages, with LB – UB mean levels comprised between 0.1 and 1.0 µg/kg. 
4.  Consumption data 
4.1.  EFSA’s Comprehensive European Food Consumption Database 
Food consumption data were derived from the EFSA Comprehensive European Food Consumption 
Database (Comprehensive database) which was built in 2010 from existing national information on 
food consumption at the individual level (EFSA, 2011; Huybrechts et al., 2011; Merten et al., 2011).  
The  Comprehensive  database  comprises consumption  data of  66,642 individuals from  32  surveys 
carried out in 22 different European countries covering the following age-groups: infants (< 1 year 
old), toddlers (≥ 1 year to < 3 years old), children (≥ 3 years to < 10 years old), adolescents (≥ 10 years 
to < 18 years old), adults (≥ 18 years to < 65 years old), elderly (≥ 65 years to < 75 years old) and very 
elderly (≥ 75 years old). Consumption data were collected with 24 h dietary recalls covering one or Maximum levels deoxynivalenol, fumonisins, zearalenone 
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two  days,  48  h  dietary  recalls,  or  through  dietary  records  covering  3  to  7  days.  A  total  of 
195,200 reporting days are available in the Comprehensive database (Table 5). 
In view of performing a chronic exposure assessment, as suggested by the EFSA Working Group on 
Food Consumption and Exposure (EFSA, 2011), only individuals with at least two days of reporting 
were  considered  (Table  5)  which  represented  a  total  of  53,728  individuals  from  28  surveys  and 
17 European countries. The average consumption level was estimated at the individual level for the 
different food groups taken into account in the exposure assessment (see Section 5). 
In view of performing an acute exposure assessment, all consumption days, i.e. days with at least one 
consumption  event  of the  food of interest,  were  considered.  For  each  consumption  day,  the  total 
amount (see Section 5) consumed that day was determined for each food group taken into account in 
the exposure assessment.  
   Maximum levels deoxynivalenol, fumonisins, zearalenone 
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Table 5:  Dietary surveys used for the chronic and acute dietary exposure assessments  
Country 
Dietary survey 
acronym 
Method  Days  Number of subjects 
(a)/ days
(b) 
Infants  Toddlers  Other 
children 
Adolescents  Adults  Elderly  Very Elderly 
elderly  Austria  ASNS  24 h recall  1          -/2123     
Belgium  Diet National 2004  24 h recall  2        584/1187  1304/2648  518/1045  712/1448 
Belgium  Regional Flanders  record  3    36/108  625/1875         
Bulgaria  NUTRICHILD  24 h recall  2  860/1720  428/856  433/867         
Bulgaria  NSFIN  24 h recall  1        -/162  -/691  -/151  -/200 
Cyprus  Childhealth  record  3        303/909       
The Czech 
Republic 
SISP04  24 h recall  2      389/778  298/596  1666/3332     
Germany  DONALD 2006  record  3    92/276  211/633         
Germany  DONALD 2007  record  3    85/255  226/678         
Germany  DONALD 2008  record  3    84/252  223/669         
Germany  National Nutrition Survey   24 h recall  2        1011/2022  10419/20838  2006/4012  490/980 
Denmark  Danish Dietary Survey  record  7      490/3426  479/3398  2822/19722  309/2159  20/140 
Greece  Regional Crete  record  3      839/2508         
Spain  AESAN  24 h recall  2          410/828     
Spain  AESAN-FIAB  record  3        86/226  981/2748     
Spain  NUT INK05  24 h recall  2      399/798  651/1302       
Spain  enKid  24 h recall  2    17/34  156/312  209/418       
Estonia  NDS_1997  24 h recall  1          -/1866     
Finland  DIPP  record  3    497/1486  933/2773         
Finland  FINDIET 2007  48 h recall  2          1575/3150  463/926   
Finland  STRIP  record  4      250/1000         
France  INCA2  record  7      482/3315  973/6728  2276/15727  264/1824  84/571 
Hungary  National Repr Surv  record  3          1074/3222  206/618  80/240 
Ireland  NSFC  record  7          958/6706     
Italy  INRAN-SCAI 2005–06  record  3  16/48  36/108  193/579  247/741  2313/6939  290/870  228/684 
Latvia  EFSA_TEST  24 h recall  2      189/377  470/949  1306/2655     
The Netherlands  DNFCS 2003  24 h recall  2          750/1500     
The Netherlands  VCP kids  record  3    322/644  957/1914         
Poland  IZZ_FAO_2000  24-h recall  1    -/79  -/409  -/666  -/2527  -/329  -/124 
Sweden  RIKSMATEN 1997-98  record  7          1210/8466     
Sweden  NFAn  24 h recall  4      1473/5875  1018/4047       
Slovakia  SK_MON_2008  24 h recall  1          -/2763     
Slovenia  CRP_2008  24 h recall  1          -/407     
The United Kingdom  NDNS  record  7          1724/12068     
(a):  Number of subjects with at least two reporting days in each age group.  
(b): Number of reporting days in each age class.  Maximum levels deoxynivalenol, fumonisins, zearalenone 
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4.2.  Consumption patterns of maize-based products in European countries 
Consumption  data  for  „Maize  grain  for  consumption‟,  „Maize  milling  fractions  with  particle  size 
> 500 µm‟  and  „Maize  milling  fractions  with  particle  size    ≤  500  µm‟  consumed  as  such  or  as 
ingredients  of  a  processed  or  composite  food  were  analysed  in  all  dietary  surveys  used  for  the 
exposure assessment. Table 6 details the food items, according to the FoodEx system, considered in 
each of these three food groups, and the processed/composite foods containing maize as ingredient, 
classified as well according to the FoodEx system, for which consumption data are available in the 
Comprehensive database. The percentage contents of maize ingredient  in the processed/composite 
foods are also indicated. These were extracted from the draft European food conversion model and 
from information provided by the requestor. Only processed/composite food containing on average 
more than 10 % maize ingredient were considered in this statement. Sweet maize, maize oil and maize 
syrup consumed as such or as ingredient of composite foods as well as the foods for infants and young 
children and alcoholic beverages made from maize grain were considered out of the scope of the 
derogation  request.  In  this  statement,  they  were  handled  in  a  similar  manner  as  the  foods  not 
containing maize. 
Table 6:  Ingredients and processed/composite foods containing maize for which consumption data 
are available in the Comprehensive Database and taken into consideration in this statement 
Food group  Food items  Processed/composite foods 
 (% content of maize) 
Maize grain for consumption  Maize grain  Maize popped (100 %) 
Maize milling fractions ≤ 500 µm  Flour , 
Starch, 
Meal 
Maize-based breakfast cereals:  
  Mixed breakfast cereals (80 %)  
  Maize meal porridge (10 %) 
Maize-based snacks: 
  Corn curls and cheese puffs (80 %) 
Other maize-based products: 
  Maize bread (37 %) Flan, sponge cakes, 
baklava (11 %)  
  Gravy (40 %) and baking ingredients (50 %) 
Maize milling fractions > 500 µm  Semolina  Maize-based breakfast cereals:  
  Corn flakes (100 %)  
  Muesli (11 %) 
  Cereal bars (15 %) 
Maize-based snacks: 
  Corn chips and tortillas (80 %) 
 
The  ranges  of  mean  and  95
th  percentile  of  average  consumption  levels  determined  for  the  total 
population (all subjects of the survey) and for the „consumption-days only‟ (reporting days with at 
least one consumption event of the food of interest) estimated for the 3 food groups are detailed in 
Appendix B. 
4.2.1.  Maize grain for consumption 
This category includes „Maize grain for direct consumption‟ as well as „Maize popped‟. According to 
the Comprehensive database, „Maize grain for consumption‟ is consumed in less than 5.8 % of the 
reporting days, whatever the age group and survey considered (Appendix B, Table B1). In all age 
groups except „other children‟ and „adolescents‟, there are surveys without any reported consumption 
event of „Maize grain for consumption‟. The highest daily portion sizes (consumption estimated over 
the consumption days) are observed in the groups of „adolescents‟ and „adults‟, with a median average 
and 95
th percentile respectively comprised between 51 and 57 g and between 88 and 100 g. The 
smallest daily portion sizes are observed in the groups of „infants‟ and „toddlers‟, with average daily 
portion sizes estimated between 3.0 and 32 g. Due to the small number of consumption days, the Maximum levels deoxynivalenol, fumonisins, zearalenone 
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average  and  95
th  percentile  consumption  levels  estimated  at  the  population  level  (considering  all 
subjects) are low, respectively comprised between 0 (no consumer) and 7.5 g/day and between 0 and 
15 g/day. 
4.2.2.  Maize milling fractions ≤ 500 µm 
This category includes maize flour, maize starch and maize meal consumed as such or as ingredients 
of breakfast cereals, extruded snacks, bread, pastries, gravy and other baking ingredients. According to 
the Comprehensive database, the percentage of „Maize milling fractions ≤ 500 µm‟ consumption days 
varies from 0 (no consumption) to 28 % across the surveys and age groups (Appendix B, Table B2). 
The absence of consumption was observed in one infant survey and one adult survey only. The highest 
daily portion sizes are observed in the groups of „adolescents‟, „adults‟, „elderly‟ and „very elderly‟, 
with a median average and 95
th percentile respectively comprised between 10 and 13 g and between 
19 and 32 g. Slightly smaller daily portion sizes are observed in the groups of „infants‟, „toddlers‟ and 
„other children‟, with a median average and 95
th percentile respectively comprised between 4.5 and 
8.1 g and between 12 and 28 g. The average and 95
th percentile consumption levels estimated at the 
population level are comprised between 0 and 7.5 g/day and between 0 and 40 g/day, respectively. The 
highest consumption levels are observed in the „adolescents‟ age group. 
4.2.3.  Maize milling fractions > 500 µm 
This category includes maize semolina consumed as such or as ingredients of corn flakes and snacks. 
According to the Comprehensive database, the percentage of „Maize milling fractions  > 500 µm‟ 
consumption days varies from 0 to 36.4 % across the surveys and age groups (Appendix B, Table B3). 
The absence of consumption was observed in one infant, one toddler and one very elderly survey only. 
The  highest  daily  portion  sizes  are  observed  in  the  groups  of  „other  children‟,  „adolescents‟  and 
„adults‟, with a median average and 95
th percentile respectively comprised between 24 and 32 g and 
between 60 and 90 g. Smaller daily portion sizes are observed in the groups of „infants‟, „toddlers‟, 
„elderly‟ and „very elderly‟, with a median average and 95
th percentile respectively comprised between 
12 and 18 g and between 16 and 44 g. The average and 95
th percentile consumption levels estimated at 
the population level are respectively comprised between 0 and 17 g/day and between less than 0 and 
50 g/day. The highest consumption levels are observed in the „other children‟ and „adolescents‟ age 
groups. 
5.  Impact of temporary maximum levels (tMLs)  
5.1.  Impact on the mean DON, ZON and FUMO levels in maize-based products 
5.1.1.  Methodology  
The impact of tMLs on the mean DON, ZON and FUMO levels in maize grains and maize-based 
products was assessed considering the results from the FranceAgriMer survey. Despite the fact that 
this survey was only representative of the French maize grains harvest and lacked representativeness 
for the European level, it was the only source of information suitable for such impact assessment. 
Indeed, this survey provided an indication of the DON, ZON and FUMO levels in maize grains as 
harvested, i.e. before any selection and rejection of non-compliant grains by maize grains suppliers or 
by maize milling factories. The IRTAC monitoring plan lacked representativeness and included data 
of heterogeneous origin (coming from different levels of the production chain). For these reasons, this 
survey  was  considered  not  suitable  for  the  impact  assessment.  The  data  from  Euromaisiers  were 
considered as the most representative of the European level. However, the results provided for the 
maize grains corresponded to levels found at the entry of the factory, i.e. after a selection and rejection 
of non-compliant grains by the maize grains suppliers. In addition, results provided for grain milling 
products corresponded to products made after the rejection of maize grains found to be non-compliant 
to the ML by the maize milling factories. For these reasons, the dataset provided by Euromaisiers was 
considered not suitable to assess the impact of tMLs on DON, ZON and FUMO levels in maize grains 
and maize-based products. Maximum levels deoxynivalenol, fumonisins, zearalenone 
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The impact of tMLs was assessed independently for DON, ZON and FUMO. The assessment was 
performed for each of the three processing levels covered by ML (unprocessed maize grain, maize 
milling fractions and maize-based products for consumption) as follows:  
  Unprocessed maize grains 
In a first scenario [A], all concentration values above the current ML for unprocessed maize grains 
were excluded from the dataset and LB/MB/UB mean levels were estimated considering the volume of 
grains represented by each sample. In a second scenario [B], all concentration values above the tML 
for unprocessed maize grains were excluded from the dataset and LB/MB/UB mean levels estimated 
considering the volume of grains represented by each sample. The volume of unprocessed maize 
grains non compliant to the current ML and tML was also estimated and expressed as a percentage of 
the total production of maize grain.  
  Maize milling fractions and maize grains for direct consumption 
Concentration values remaining after the exclusion of values above the current ML and tML defined 
for the unprocessed maize grains were adjusted with transfer rates in order to reflect levels in maize 
milling fractions and in maize grains for direct consumption. The transfer rate was set at 1 for maize 
grains for direct consumption. For maize milling fractions, it was set at the ratio between the tML in 
maize milling fractions and the tML in the unprocessed maize grain (Table 7). For example, for DON, 
it was set at 0.67 for the „Maize milling fractions ≤ 500 µm‟, which corresponds to the ratio between 
1500 µg/kg – the tML for DON in „Maize milling fractions ≤ 500 µm‟ – and 2250 µg/kg – the tML for 
DON in „Unprocessed maize grains‟. This approach was motivated by the fact  that the requestor 
reported  higher  transfer  rates  in  products  made  from  2013  harvest  than  usually  observed.  It  was 
consequently considered the tMLs to better reflect the average transfer rate in products made from the 
2013 harvest than the current MLs.   
Table 7:  Transfer rates from unprocessed maize grain to maize milling fractions considered in this 
statement 
Mycotoxin  Maize milling fractions ≤ 500 µm  Maize milling fractions > 500 µm 
DON  0.67  0.44 
FUMO  0.78  0.42 
ZON  0.80  0.60 
 
Adjusted concentration values above the current MLs and tMLs defined for maize milling fractions 
and maize grains for direct consumption were excluded from the dataset and LB/MB/UB mean levels 
estimated considering the volume of products represented by each sample. The percentage of maize 
milling fractions and maize grains for direct consumption non compliant to the current MLs and tMLs 
was also estimated. 
  Maize-based products for direct consumption 
Concentration values remaining after the exclusion of values above the current ML and the tML 
defined  for  maize  milling  fractions  were  finally  adjusted  in  order  to  reflect  levels  in 
processed/composite  maize-based  products,  considering  the  percentage  content  of  maize  milling 
fractions  in  the  final  products.  The  different  kinds  of  processed/composite  products  and  maize 
percentage contents described in Table 6 were considered. In this assessment, it was assumed that 
other ingredients of the processed/composite maize-based products did not contain DON, FUMO and 
ZON. For example, „Muesli‟ usually contains different types of grains (wheat, oat, rice, maize, etc…). Maximum levels deoxynivalenol, fumonisins, zearalenone 
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It was considered that only the maize fraction of „Muesli‟ was containing DON, FUMO and ZON, and 
not the other grains. In addition, it was assumed that there were no processing effects (bread-baking, 
extrusion cooking, etc.) on the DON, FUMO and ZON levels. Adjusted concentration values above 
the current MLs and tMLs defined for the different maize-based snacks and breakfast cereals and other 
maize-based foods taken into consideration were excluded from the dataset and LB/MB/UB mean 
levels estimated considering the volume of products represented by each sample. The percentage of 
processed/composite products non compliant to the current MLs and tMLs was also estimated. 
For each of the three processing levels covered by ML, the impact of tMLs was described as the 
percentage  difference  between  the  mean  MB  level  estimated  after  the  exclusion  of  concentration 
values above the tML and the mean level estimated after the exclusion of concentration values above 
the current ML. 
5.1.2.  Results of the impact on occurrence levels 
  Unprocessed maize grains and maize milling fractions 
Table 8 shows the mean DON, FUMO and ZON levels in unprocessed maize grains and in maize 
milling fractions below and above 500 µm estimated considering the current ML and the tML. 
The mean levels estimated in unprocessed maize grains and maize milling fractions for DON after the 
exclusion of samples non compliant to the tML are increased by 16 – 18 % compared to the mean 
levels estimated after the exclusion of samples non compliant to the current ML. The mean levels 
estimated in unprocessed maize grains and maize milling fractions for ZON after the exclusion of 
samples non compliant to the tML are increased by 25 – 27 % compared to the mean levels estimated 
after the exclusion of samples non compliant to the current ML. Results are more heterogeneous for 
FUMO.  Whereas  the  percentage  increase  of  the  mean  level  after  the  exclusion  of  samples  non 
compliant to the tML is estimated at 7.8 % for unprocessed maize grains, it is estimated at 12 % for 
the milling fractions with particle size above 500 µm and 23 % for the milling fractions with particle 
size below 500 µm. 
Some maize milling fractions appear to be non compliant to the current ML, even if made from maize 
grains compliant to the current ML. Indeed, 3.3 % of maize milling fractions with particle size below 
500 µm were estimated as non-compliant to the current ML for FUMO, and less than 0.8, 1.8 and 
2.2 % of milling fractions with particle size above 500 µm were estimated as non-compliant to the 
current ML for FUMO, ZON and DON, respectively. The maize milling fractions made from grains 
compliant to the tML were estimated to be compliant to their corresponding tML. 
 
Table 8:  Mean DON, FUMO and ZON levels estimated in unprocessed maize grains and maize 
milling fractions considering current MLs and tMLs expressed in µg/kg 
Food group 
Scenario A (current ML)  Scenario B (tML)  % 
% 
NC
(a) 
Mean  
MB [LB – UB]
(b) 
% 
NC
(a) 
Mean 
 MB [LB – UB]
(b) 
INC
(c) 
DON 
Unprocessed maize grains  23  996 [993; 1000]  7.9  1156 [1154; 1159]  16 
Maize milling fractions ≤ 500 µm  0  668 [665; 670]  0  775 [773; 777]  16 
Maize milling fractions > 500 µm  2.2  431 [430; 433]  0  509 [508; 510]  18 
FUMO 
Unprocessed maize grains  9.5  619 [564; 673]  8.3  666 [612; 720]  7.6 
Maize milling fractions ≤ 500 µm  3.3  422 [378; 466]  0  520 [478; 561]  23 
Maize milling fractions > 500 µm  0.8  251 [228; 274]  0  280 [257; 302]  12 
   Maximum levels deoxynivalenol, fumonisins, zearalenone 
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Table 8:   Continued 
Food group 
Scenario A (current ML)  Scenario B (tML)  % 
% 
NC
(a) 
Mean  
MB [LB – UB]
(b) 
% 
NC
(a) 
Mean 
 MB [LB – UB]
(b) 
INC
(c) 
ZON 
Unprocessed maize grains  27  167 [166; 167]  13  208 [207; 208]  25 
Maize milling fractions ≤ 500 µm  0  133 [133; 134]  0  166  25 
Maize milling fractions > 500 µm  1.8  98.0 [97.8; 98.2]  0  125 [124; 125]  27 
(a):  % NC: percentage of products (in a volume basis) non compliant to the ML.  
(b):  Mean MB [LB – UB]: mean middle bound [lower bound – upper bound]. When the LB, MB and UB estimates are 
equal, only one estimate is indicated. 
(c):  % INC: percentage difference determined as the difference between the mean MB obtained with scenario B (tML) and 
mean MB obtained with scenario A (current ML) divided by the mean MB obtained with scenario A.  
Note: In order to avoid the impression of too high precision, the numbers for occurrence values are rounded to 3 figures and 
the percentages to 2 figures.. 
 
 
  Maize grains and maize-based products for direct consumption 
Table  9  shows  the  mean  DON,  FUMO  and  ZON  levels  estimated  in  maize  grain  for  direct 
consumption and in some maize-based foods considering current ML and tML. 
Depending on the kind of ingredient (grain, milling fractions ≤ 500 µm, milling fractions > 500 µm) 
and  its  percentage  content,  the  percentage increase of  DON  and  FUMO  mean  levels  in  the final 
processed/composite products ranged between 12 and 58 %. The percentage increase is higher for 
ZON, which ranged between 25 and 99 %.  
   Maximum levels deoxynivalenol, fumonisins, zearalenone 
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Table 9:  Mean DON, FUMO and ZON levels estimated in maize intended for direct consumption 
and in maize-based processed/composite foods considering current MLs and tMLs expressed in µg/kg 
Food group 
Scenario A (current ML)  Scenario B (tML)  % 
% 
NC
(a) 
Mean  
MB [LB – UB]
 (b) 
% 
NC
(a) 
Mean 
 MB [LB – UB]
(b) 
INC
(c) 
DON 
Maize grain for consumption   73  419 [406; 431]  62  596 [588; 603]  42 
Maize-based breakfast cereals and snacks          
- made of  maize milling fractions ≤ 500 µm:         
- 80 %  59  302 [298; 307]  29  477 [475; 480]  58 
- 10 %   0  66.8 [66.5; 67.0]  0  77.5 [77.3; 77.7]  16 
- made of  maize milling fractions >500 µm:         
- 100 %   44  297 [294; 300]  18  431 [430; 433]  45 
- 80 %   11  319 [318; 320]  2.6  398 [397; 399]  25 
- 15 %   0  64.7 [64.4; 64.9]  0  76.3 [76.1; 76.5]  18 
- 11 %   0  47.4 [47.3; 47.6]  0  56.0 [55.8; 56.1]  18 
Other maize-based products           
- made of  maize milling fractions ≤ 500 µm:         
- 50 %   9.7  311 [309; 312]  0  387 [387; 388]  25 
- 40 %   0  267 [266; 268]  0  310 [309; 311]  16 
- 37 %  0  245 [244; 246]  0  284 [284; 285]  16 
- 11 %   0  71.4 [71.2; 71.7]  0  82.9 [82.7; 83.1]  16 
FUMO 
Maize grain for consumption   20  279 [211; 347]  16  346 [282; 410]  24 
Maize-based breakfast cereals and snacks          
- made of  maize milling fractions ≤ 500 µm:         
- 80 %  15  189 [148; 230]  10  274 [237; 311]  45 
- 10 %   0  42.2 [37.8; 46.6]  0  51.9 [47.8; 56.1]  23 
- made of  maize milling fractions >500 µm:         
- 100 %   11  160 [134; 186]  2.1  251 [228; 274]  57 
- 80 %   3.1  178 [159; 197]  1.3  208 [190; 226]  17 
- 15 %   0  37.6 [34.1; 41.0]  0  42 [38.6; 45.3]  12 
- 11 %   0  27.6 [25.0; 30.1]  0  30.8 [28.3; 33.3]  12 
Other maize-based products           
- made of  maize milling fractions ≤ 500 µm:         
- 50 %   0  211 [189; 233]  1.3  241 [220; 263]  14 
- 40 %   0  169 [151; 186]  0  208 [191; 225]  23 
- 37 %  0  155 [139; 171]  0  191 [175; 206]  23 
- 11 %   0  45.2 [40.5; 49.9]  0  55.6 [51.1; 60.1]  23 
ZON 
Maize grain for consumption   71  53.1 [51.9; 54.3]  47  106 [105; 106]  99 
Maize-based breakfast cereals and snacks          
- made of  maize milling fractions ≤ 500 µm:         
- 80 %  53  50.6 [50.2; 51.1]  24  95.9 [95.7; 96.2]  90 
- 10 %   0  13.3 [13.3; 13.4]  0  16.6 [16.6; 16.6]  25 
- made of  maize milling fractions >500 µm:         
- 100 %   48  51.7 [51.3; 52.1]  18  98.0 [97.8; 98.2]  89 
- 80 %   33  52.3 [52.0; 52.5]  9.3  87.4 [87.3; 87.6]  67 
- 15 %   0  14.7 [14.7; 14.7]  0  18.7 [18.6; 18.7]  27 
- 11 %   0  10.8 [10.8; 10.8]  0  13.7 [13.7; 13.7]  27 
 
 
 
 Maximum levels deoxynivalenol, fumonisins, zearalenone 
 
EFSA Journal 2014;12(5):3699  29 
Table 9:  Continued. 
Food group 
Scenario A (current ML)  Scenario B (tML)  % 
% 
NC
(a) 
Mean  
MB [LB – UB]
 (b) 
% 
NC
(a) 
Mean 
 MB [LB – UB]
(b) 
INC
(c) 
ZON 
Other maize-based products           
- made of  maize milling fractions ≤ 500 µm:         
- 50 %   23  50.1 [49.9; 50.2]  0  83.0 [82.9; 83.1]  66 
- 40 %   9.4  48.0 [47.8; 48.1]  0  66.4 [66.3; 66.5]  38 
- 37 %  1.7  48.0 [47.9; 48.1]  0  60.9 [60.8; 61.0]  27 
- 11 %   0  14.3 [14.2; 14.3]  0  17.8 [17.7; 17.8]  25 
(a):  % NC: percentage of products (in a volume basis) non compliant to the ML. 
(b):  Mean MB [LB – UB]: mean middle bound [lower bound – upper bound]. 
(c):  % INC: percentage difference determined as the difference between the mean MB obtained with scenario B (tML) and 
mean MB obtained with scenario A (current ML) divided by the mean MB obtained with scenario A.  
Note: In order to avoid the impression of too high precision, the numbers for occurrence values are rounded to 3. 
 
Some final processed/composite products appear to be non compliant to the current ML, even if made 
from ingredients compliant to the current ML. This is especially the case of processed/composite 
products containing more than 80 % maize as ingredient, with non compliant rates comprised between 
11 and 73 % for DON, between 3.1 and 20 % for FUMO and between 33 and 71 % for ZON. Lower 
non compliant rates are estimated for the same products made from ingredients compliant to the tML, 
comprised between 2.6 and 62 % for DON, between 1.3 and 16 % for FUMO and between 9.3 and 
47 % for  ZON.  For  ZON,  levels  above the  current ML  are also  observed in products  containing 
between  37  and  50  %  of  maize  milling  fractions  ≤  500  µm.  Same  products  made  from  milling 
fractions compliant to the tML are estimated to be compliant to their corresponding tML. 
 
5.2.  Impact on chronic exposure levels to DON, FUMO and ZON 
5.2.1.  Methodology  
Chronic exposure was assessed at the individual level by multiplying the mean consumption for each 
food with the corresponding mean concentration, summing up the respective intakes throughout the 
diet,  and  finally  dividing  the  results  by  the  individual‟s  body  weight.  The  mean  as  well  as  the 
95
th percentile of exposure were then derived for each population group (i.e. [survey and age group] 
combinations). The percentage of individuals with an exposure higher than the chronic health-based 
guidance value (HBGV) was also estimated. Finally, the contribution of maize-based products to total 
exposure  was  determined  for  each  population  group,  as  the  ratio  between  the  average  exposure 
resulting from the consumption of maize-based products and the total average exposure. 
In  a  first  scenario  [A],  the  chronic  exposure  was  assessed  considering  the  mean  concentrations 
estimated after the exclusion of concentration values above the current MLs  for maize grains for 
consumption,  milling  fractions  of  maize  consumed  as  such  or  as  ingredients  and  in  maize-based 
processed products (see Tables 8 and 9, Scenario A). In a second scenario [B], the chronic exposure 
was assessed considering the mean concentration estimated after the exclusion of concentration values 
above the tMLs (see Tables 8 and 9, Scenario B). In both scenarios, the mean levels estimated in the 
previous assessments were considered for the other foods, as detailed in Appendix A. The percentage 
difference between the exposure levels obtained from the two calculations (scenarios A and B) was 
characterised for each [survey and age group] combination across the Comprehensive Database. 
Calculations were done independently for DON, FUMO and ZON. Maximum levels deoxynivalenol, fumonisins, zearalenone 
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5.2.2.  Results of the impact on chronic exposure levels 
Tables  10,  11  and  12  present  the  ranges  (minimum,  median  and  maximum)  of  the  mean  and 
95
th percentile exposure levels and of the percentage of subjects with an exposure above the chronic 
HBGVs, estimated across the different surveys and age groups for the current MLs and tMLs for 
DON, ZON and FUMO, respectively. Whereas all surveys and age groups were used to derive the 
ranges of the mean exposure levels, only those with more than 60 subjects were used to derive the 
ranges of the 95
th percentiles and percentages of subjects above the chronic HBGV. For each age 
group, the minimum and maximum relative contribution of maize-based products in percentage to the 
overall  LB  mean  exposure  determined  across  the surveys  are  provided  in  Appendix  C.  Table  13 
summarizes the percentage increase of exposure from scenario A to B estimated across surveys for 
each age group.  
  DON 
The mean exposure levels estimated in scenario A, reflecting exposure resulting from the specific 
contamination of the 2013 maize grains harvest and implementation of current MLs, are in the region 
of  the  group  PMTDI  of  1  μg/kg  b.w.  for  some  surveys  covering  children  age  groups  („infant‟, 
„toddlers‟, „other children‟) (Table 10). The mean exposure levels range between 0.22 and 0.98 µg/kg 
b.w. per day at the LB and 0.52 and 1.11 µg/kg b.w. per day at the UB. The 95
th percentile of exposure 
for these three groups is between 0.94 and 1.79 µg/kg b.w. per day at the LB and between 0.99 and 
2.10 µg/kg b.w. per day at the UB. In the surveys covering adult age groups („adolescents‟, „adults‟, 
„elderly‟ and „very elderly‟), the mean exposure levels, being between 0.18 and 0.55 µg/kg b.w. per 
day at the LB and 0.21 and 0.56 µg/kg b.w. per day at the UB, remain below the group PMTDI. 
However, the 95
th percentile of exposure is in the region of the group PMTDI for some surveys, being 
between 0.36 and 1.04 µg/kg b.w. per day at the LB and 0.38 and 1.05 µg/kg b.w. per day at the UB.  
Despite the higher DON levels in maize-based products considered in this statement in comparison to 
the  levels  considered  in  the  previous  assessment  (EFSA  CONTAM  Panel,  2013),  the  exposure 
estimates are in the same ranges (Table 10). This is explained by the fact that the total exposure is 
mainly driven by foods other than maize-based ones (Appendix C, Table C.1), representing between 
75 and 100 % of the total exposure depending on the surveys and age groups.   
Depending on the surveys and age groups (with the exclusion of the „infants‟ age group), the mean and 
95
th percentile exposure levels (LB and UB) estimated in scenario B – considering average DON 
levels in maize-based products resulting from the implementation of the tML – resulted up to 20 % 
higher than the levels estimated for the chronic exposure with the current ML (Table 13). The highest 
percentage increase is observed in the „adolescents‟ age group, who are the highest consumers of 
maize-based products (see Section 4.2). The percentage difference of 95
th percentile exposure levels 
estimated between the two scenarios is 4.5 % in the „infants‟ age group, due to the low consumption of 
the products concerned by the derogation request.    Maximum levels deoxynivalenol, fumonisins, zearalenone 
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Table 10:  Chronic exposure to DON estimated in scenarios A and B expressed in µg/kg b.w. per day across surveys for each age group 
Background exposure (EFSA, 2013)  Scenario A (current MLs)  Scenario B (tMLs) 
  Mean 
LB-UB 
P95 
LB-UB 
Mean 
LB-UB 
P95 
LB-UB 
Percentage above                      
HBGV LB-UB
(a) (%) 
Mean 
LB-UB 
P95 
LB-UB 
Percentage above 
HBGV LB-UB
(a) (%) 
Infants (N
(b) = 2/1) 
Minimum  0.22 - 0.78  1.05 - 1.86  0.22 - 0.78  1.06 - 1.89  5.8 - 33  0.22 - 0.78  1.11 - 1.92  6.4 - 33 
Median  -   -   -   -   -   -   -   -  
Maximum  0.30 - 0.79  1.05 - 1.86  0.31 - 0.80  1.06 - 1.89  5.8 - 33  0.32 - 0.81  1.11 - 1.92  6.4 - 33 
Toddlers (N
(b) = 9/6) 
Minimum  0.47 - 0.70  0.94 - 1.20  0.53 - 0.72  1.00 - 1.28  5.4 - 17  0.54 - 0.73  1.02 - 1.4  6.1 - 18 
Median  0.56 - 0.92  1.02 - 1.72  0.68 - 0.85  1.18 - 1.67  11 - 26  0.69 - 0.86  1.26 - 1.84  11 - 28 
Maximum  0.94 - 1.10  1.55 - 2.13  0.98 - 1.11  1.79 - 2.10  44 - 52  1.03 - 1.12  1.99 - 2.13  46 - 54 
Other children (N
(b) = 17/17) 
Minimum  0.45 - 0.49  0.83 - 0.92  0.48 - 0.52  0.94 - 0.99  2.7 - 4.2  0.50 - 0.54  0.98 - 1.03  4.2 - 6.5 
Median  0.59 - 0.64  1.00 - 1.11  0.62 - 0.67  1.17 - 1.26  12 - 15  0.64 - 0.70  1.23 - 1.41  12 - 15 
Maximum  0.94 - 0.96  1.65 - 1.73  0.98 – 1.00  1.76 - 1.78  45 - 46  1.02 - 1.04  1.91 - 1.93  47 - 49 
Adolescents (N
(b) = 12/12) 
Minimum  0.30 - 0.32  0.63 - 0.66  0.32 - 0.33  0.68 - 0.69  0 - 0.2  0.34 - 0.35  0.74 - 0.75  1.1 - 1.3 
Median  0.38 - 0.41  0.73 - 0.77  0.41 - 0.43  0.80 - 0.81  1.1 - 1.5  0.42 - 0.46  0.87 - 0.89  2.2 - 2.7 
Maximum  0.53 - 0.55  1.00 - 1.04  0.55 - 0.56  1.04 - 1.05  6.7 - 7.4  0.56 - 0.57  1.04 - 1.13  7.0 - 7.4 
Adults (N
(b) = 15/15) 
Minimum  0.18 - 0.24  0.35 - 0.47  0.19 - 0.22  0.39 - 0.42  0  0.19 - 0.22  0.39 - 0.43  0 
Median  0.25 - 0.32  0.49 - 0.59  0.26 - 0.28  0.50 - 0.52  < 0.1  0.27 - 0.29  0.54 - 0.56  0.2 
Maximum  0.35 - 0.43  0.63 - 0.97  0.36 - 0.37  0.64 - 0.66  0.6  0.36 - 0.37  0.66 - 0.68  0.6 
Elderly (N
(b) = 7/7) 
Minimum  0.17 - 0.21  0.36 - 0.43  0.18 - 0.21  0.36 - 0.38  0  0.18 - 0.21  0.36 - 0.40  0 
Median  0.24 - 0.28  0.48 - 0.52  0.23 - 0.24  0.47 - 0.48  0  0.23 - 0.24  0.48  0 
Maximum  0.31 - 0.32  0.51 - 0.59  0.32 - 0.33  0.52 - 0.54  < 0.1  0.32 - 0.33  0.54 - 0.55  < 0.1 
Very elderly (N
(b) = 6/5) 
Minimum  0.22 - 0.25  0.42 - 0.44  0.22 - 0.23  0.41 - 0.43  0  0.22 - 0.23  0.42 - 0.44  0 
Median  0.24 - 0.28  0.52 - 0.55  0.23 - 0.24  0.50 - 0.51  0  0.24  0.51  0 
Maximum  0.33 - 0.34  0.56 - 0.57  0.33 - 0.35  0.57 - 0.58  0.3  0.34 - 0.35  0.60 - 0.61  0.3 
LB: lower bound; UB: upper bound; P95: 95
th percentile. (a) Percentage above chronic HBGV: Percentage of subjects with an exposure above the health-based guidance value; (b): Number of 
surveys used to derive the minimum/median/maximum mean exposure levels/number of surveys used to derive the minimum/median/maximum 95
th percentile exposure levels and percentages 
of individuals with an exposure above the chronic HBGV.  
Note: In order to avoid the impression of too high precision, the numbers for exposure estimates are rounded to 3 figures, and the percentages to 2 figures.  When LB and UB estimates are 
identical, only one estimate is provided.  Maximum levels deoxynivalenol, fumonisins, zearalenone 
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Table 11:  Chronic exposure to ZON estimated in scenarios A and B expressed in ng/kg b.w. per day across surveys for each age group 
Background exposure (EFSA, 2011)  Scenario A (current MLs)  Scenario B (tMLs) 
  Mean 
LB-UB 
P95 
LB-UB 
Mean 
LB-UB 
P95 
LB-UB 
Percentage above 
HBGV LB-UB
(a) (%) 
Mean 
LB-UB 
P95 
LB-UB 
Percentage above 
HBGV LB-UB
(a) (%) 
Infants (N
(b) = 2/1) 
Minimum  3.3 - 87  33   9.7 - 115  57 - 292  0.3 - 9.2  9.7 - 115  68 - 301  0.7 - 9.8 
Median  -   -    -  -   -   -   -   -  
Maximum  9.4 - 88  217  16 - 126  57 - 292  0.3 - 9.2  19 - 128  68 - 301  0.7 - 9.8 
Toddlers (N
(b) = 9/6) 
Minimum  9.3 - 51  24 - 104  14 - 62  52 - 128  0  16 - 63  64 - 151  < 0.1 - 0.9 
Median  13 - 83  31 - 182  20 - 107  82 - 217  0.5 - 3.3  25 - 111  106 - 260  0.9 - 6.3 
Maximum  23 - 100  50 - 277  53 - 118  145 - 303  1.0 - 9.2  70 - 133  233 - 304  4.2 - 9.8 
Other children (N
(b) = 17/17) 
Minimum  5.7 - 29  9.9 - 59  17 - 45  47 - 99  0  21 - 53  61 - 108  0 
Median  11 - 44  22 - 80  27 - 63  78 - 125  0 - 0.1  38 - 73  114 - 153  0.4 - 0.8 
Maximum  22 - 75  42 - 124  48 - 103  148 - 200  0.5 - 1.6  64 - 118  233 - 275  3.7 - 7.2 
Adolescents (N
(b) = 12/12) 
Minimum  3.6 - 17  7.5 - 38  11 - 30  35 - 68  0  13 - 32  44 - 76  0 
Median  6.1 - 26  15 - 53  17 - 40  51 - 82  0  23 - 47  74 - 110  < 0.1 - 0.2 
Maximum  12 - 42  26 - 76  35 - 64  70 - 117  0.5  40 - 66  111 - 133  0.5 – 1.0 
Adults (N
(b) = 15/15) 
Minimum  2.4 - 14  4.7 - 28  6.3 - 19  16 - 42  0  7.7 - 20  18 - 46  0 
Median  4.3 - 18  9.5 - 35  8.6 - 29  30 - 58  0  11 - 30  42 - 64  0 
Maximum  7.2 - 29  14 - 54  21 - 42  46 - 83  0  22 - 43  72 - 95  0.2 
Elderly (N
(b) = 7/7) 
Minimum  2.0 - 13  3.5 - 25  4.4 - 17  11 - 33  0  5.1 - 17  12 - 33  0 
Median  3.4 - 16  7.5 - 31  6.2 - 20  17 - 42  0  6.6 - 21  26 - 47  0 
Maximum  6.4 - 26  12 - 42  13 - 35  38 - 62  0  14 - 36  45 - 67  0 
Very elderly (N
(b) = 6/5) 
Minimum  2.3 - 12  7.0 - 26  4.5 - 18  13 - 37  0  5.7 - 19  13 - 41  0 
Median  2.9 - 16  7.7 - 35  6.5 - 22  20 - 46  0  7.0 - 23  26 - 46  0 
Maximum  7.1 - 29  13 - 47  12 - 34  29 - 56  0  13 - 35  46 - 65  0 
LB: lower bound; UB: upper bound; P95: 95
th percentile. (a) Percentage above chronic HBGV: Percentage of subjects with an exposure above the health-based guidance value; (b): Number of 
surveys used to derive the minimum/median/maximum mean exposure levels/number of surveys used to derive the minimum/median/maximum 95
th percentile exposure levels and percentages 
of individuals with an exposure above the chronic HBGV.  
Note: In order to avoid the impression of too high precision, the numbers for exposure estimates and percentages are rounded to 2 figures.. When LB and UB estimates are identical, only one 
estimate is provided.    Maximum levels deoxynivalenol, fumonisins, zearalenone 
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Table 12:  Chronic exposure to FUMO estimated in scenarios A and B expressed in µg/kg b.w. per 
day across surveys for each age group 
  Scenario A (current MLs)  Scenario B (tMLs) 
  Mean 
LB-UB 
P95 
LB-UB 
Percentage 
above HBGV 
LB-UB
(a) (%) 
Mean 
LB-UB 
P95 
LB-UB 
Percentage 
above HBGV 
LB-UB
(a) (%) 
Infants (N
(b) = 2/1) 
Minimum  0.17 - 0.47  0.77 - 1.94  0.1 - 4.5  0.17 - 0.47  0.79 - 1.96  0.1 - 4.7 
Median                   
Maximum  0.18 - 0.59  0.77 - 1.94  0.1 - 4.5  0.19 - 0.60  0.79 - 1.96  0.1 - 4.7 
Toddlers (N
(b) = 9/6) 
Minimum  0.34 - 0.81  0.77 - 1.91  0 - 4.2  0.35 - 0.82  0.79 - 1.93  < 0.1 - 4.6 
Median  0.58 - 1.49  1.33 - 2.54  1.2 - 16  0.58 - 1.50  1.39 - 2.59  1.2 - 16 
Maximum  0.80 - 1.74  1.58 - 2.75  2.7 - 22  0.8 - 1.74  1.59 - 2.75  2.7 - 24 
Other children (N
(b) = 17/17) 
Minimum  0.25 - 0.61  0.54 - 1.09  0 - 0.1  0.26 - 0.62  0.58 - 1.14  < 0.1 - 0.1 
Median  0.52 - 1.29  1.30 - 2.23  0.5 - 8.6  0.53 - 1.29  1.30 - 2.23  0.6 - 8.6 
Maximum  1.52 - 2.11  3.44 - 4.39  25 - 47  1.54 - 2.13  3.46 - 4.47  26 - 48 
Adolescents (N
(b) = 12/12) 
Minimum  0.20 - 0.55  0.45 - 1.03  0  0.22 - 0.57  0.49 - 1.05  0 
Median  0.33 - 0.75  0.87 - 1.48  0 - 1.2  0.34 - 0.76  0.89 - 1.48  < 0.1 - 1.2 
Maximum  0.81 - 1.19  1.76 - 2.30  1.7 - 9.9  0.84 - 1.22  1.76 - 2.37  2.6 - 10 
Adults (N
(b) = 15/15) 
Minimum  0.04 - 0.17  0.11 - 0.32  0  0.04 - 0.17  0.12 - 0.33  0 
Median  0.16 - 0.47  0.43 - 0.92  0  0.17 - 0.47  0.44 - 0.92  0 
Maximum  0.47 - 0.73  0.97 - 1.36  0.3 - 0.6  0.47 - 0.73  0.98 - 1.36  0.3 - 0.6 
Elderly (N
(b) = 7/7)  
Minimum  0.03 - 0.15  0.08 - 0.31  0  0.03 - 0.15  0.09 - 0.31  0 
Median  0.12 - 0.40  0.29 - 0.78  0  0.12 - 0.40  0.31 - 0.78  0 
Maximum  0.29 - 0.53  0.61 - 0.95  < 0.1  0.29 - 0.53  0.61 - 0.95  < 0.1 
Very elderly (N
(b) = 6/5) 
Minimum  0.09 - 0.35  0.22 - 0.71  0  0.09 - 0.35  0.23 - 0.72  0 
Median  0.14 - 0.42  0.32 - 0.81  0  0.15 - 0.42  0.32 - 0.81  0 
Maximum  0.30 - 0.57  0.67 - 1.05  0.2  0.30 - 0.57  0.68 - 1.05  0.2 
  LB: lower bound; UB: upper bound; P95: 95
th percentile.  
(a):  Percentage above chronic HBGV: Percentage of subjects with an exposure above the health-based guidance value;  
(b):  Number of surveys used to derive the minimum/median/maximum mean exposure levels/number of surveys used to 
derive the minimum/median/maximum 95
th percentile exposure levels and percentages of individuals with an exposure 
above the chronic HBGV.  
Note: In order to avoid the impression of too high precision, the numbers for exposure estimates are rounded to 3 figures, and 
the percentages to 2 figures. When LB and UB estimates are identical, only one estimate is provided.    
 
 
  ZON 
The mean exposure levels estimated in scenario A, reflecting exposure resulting from the specific 
contamination of the 2013 maize grains harvest and implementation of current MLs, are lower than the 
chronic  HBGV (TDI) of 250 ng/kg b.w. in all age groups and surveys (Table 11). The mean exposure 
levels range between 9.7 and 53 ng/kg b.w. per day at the LB and 45 and 126 ng/kg b.w. per day at the 
UB in the children age groups. In the adults age groups, the mean exposure levels range between 
4.4 and 35 ng/kg b.w. per day at the LB and 17 and 64 ng/kg b.w. per day at the UB. In the children 
age groups, whereas the LB estimate of the 95
th percentile of exposure is below the TDI, the UB 
estimate is above the TDI in some surveys. Indeed, the LB 95
th percentile estimate is between 47 and 
148 ng/kg b.w. per day and the UB 95
th percentile estimate between 99 and 303 ng/kg b.w. per day. In 
the adult age groups, the 95
th percentile of exposure is always below the TDI, being between 11 and 
70 ng/kg b.w. per day at the LB and between 33 and 117 ng/kg b.w. per day at the UB.  Maximum levels deoxynivalenol, fumonisins, zearalenone 
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Such estimates are higher than those estimated in previous assessment (EFSA CONTAM Panel, 2011) 
(Table 11) especially at the LB. In the previous assessment, the maximum mean exposure level was 
estimated at 23 ng/kg b.w. per day (vs. 53 ng/kg b.w. per day in this assessment) at the LB and at 
100 ng/kg b.w. per day (vs. 126 ng/kg b.w. per day in this assessment) at the UB.  The maximum 
95
th percentile exposure level was estimated at 50 ng/kg b.w. per day (vs. 148 ng/kg b.w. per day in 
this  assessment)  at  the  LB  and  at  277  ng/kg  b.w.  per  day  (vs.  303  ng/kg  b.w.  per  day  in  this 
assessment). This is explained by the fact that the total exposure is mainly driven by maize-based 
products, which represent up to 77.8 % of the total exposure depending on the surveys and age groups 
(Appendix C, Table C.3). 
Depending on the surveys and age groups (with the exclusion of the „infants‟ age group), the mean and 
95
th percentile exposure levels (LB and UB estimates) estimated in scenario B – considering average 
ZON levels in maize-based products resulting from the implementation of the tML – are up to 83 % 
higher than the levels estimated for the chronic exposure with the current ML (Table 13). The highest 
percentage increase is observed in the „other children‟ and „adolescents‟ age groups. The percentage 
difference  of  95
th  percentile  exposure levels estimated  between the two  scenarios  is  19 %  in the 
„infants‟ age group due to the low consumption of the products concerned by the derogation request.    
  FUMO 
The mean exposure levels estimated in scenario A, reflecting exposure resulting from the specific 
contamination of the 2013 maize grains harvest and implementation of current MLs, are in the region 
of the HBGV (group PMTDI) of 2 μg/kg b.w. for some surveys covering children age groups (Table 
11). Indeed, the mean exposure levels range between 0.17 and 1.52 µg/kg b.w. per day at the LB and 
0.47 and 2.11 µg/kg b.w. per day at the UB. The 95
th percentile of exposure was between 0.54 and 
3.44 µg/kg b.w. per day at the LB and between 1.09 and 4.39 µg/kg b.w. per day at the UB. In the 
surveys covering adult age groups, the mean exposure levels remain below the group PMTDI , being 
between 0.03 and 0.81 µg/kg b.w. per day at the LB and 0.15 and 1.19 µg/kg b.w. per day at the UB. 
However, the 95
th percentile of exposure is in the region of the group PMTDI for some surveys, being 
between 0.08 and 1.76 µg/kg b.w. per day at the LB and 0.31 and 2.30 µg/kg b.w. per day at the UB. 
Maize-based foods were found to represent from 0.4 to 22 % of the total exposure in all age groups 
except „infants‟. The percentage contribution of maize-based foods to the total exposure of „infants‟ 
was ranging from 0 to 8.2 % (Appendix C, Table C.2). 
Depending on the surveys and age groups (with the exclusion of the „infants‟ age group), the mean and 
95
th percentile exposure levels (LB and UB estimates) estimated in scenario B – considering average 
DON levels in maize-based products resulting from the implementation of the tML – are up to 17 % 
higher  than  the  levels  estimated  for  the  chronic  exposure  with  the  current  ML  (Table  13).  The 
percentage difference of 95
th percentile exposure levels estimated between the two scenarios is less 
than 1.8 % in the „infants‟ age group due to the low consumption of the products concerned by the 
derogation request. 
   Maximum levels deoxynivalenol, fumonisins, zearalenone 
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Table 13:  Percentage increase of exposure from scenario A to scenario B estimated across surveys 
for each age group  
Age group 
Median percentage increase of exposure [minimum; maximum]
(a) 
Mean exposure  P95 exposure 
LB  UB  LB  UB 
    DON     
Infants  -
(b) [0; 2.2]  -
(b) [0; 0.9]  4.5  1.6 
Toddlers  1.9 [0.6; 4.5]  1.4 [0.6; 4.1]  7.4 [1.8; 11]  7.7 [0; 15] 
Other children  4.1 [1.5; 8.6]  3.8 [1.3; 8.2]  6.1 [0; 18]  5.7 [0; 14] 
Adolescents  3.9 [1.4; 12]  3.5 [1.4; 11]  6.9 [0.2; 20]  6.1 [0.4; 19] 
Adults  2.1 [0.8; 8.3]  2.0 [0.8; 7.6]  4.0 [0.4; 16]  3.0 [0.4; 12] 
Elderly  1.0 [0.1; 2.2]  1.0 [0.1; 2.1]  1.4 [0; 4.5]  1.5 [0; 3.4] 
Very elderly  1.2 [0.1; 1.6]  1.2 [0.1; 1.5]  2.8 [0; 5.2]  1.5 [0; 3.9] 
    FUMO     
Infants  -
(b) [0; 1.8]  -
(b) [0; 0.5]  1.8  0.8 
Toddlers  1.2 [0.5; 4.1]  0.3 [0.2; 1.3]  3.0 [0.3; 6.3]  1.5 [0; 2.2] 
Other children  2.1 [1; 9.4]  1.0 [0.4; 3.7]  2.3 [0; 12]  1.5 [0; 7.5] 
Adolescents  2.6 [0.9; 10]  1.0 [0.4; 3.4]  2.7 [0; 9.3]  1.0 [0; 4.3] 
Adults  2.1 [0.5; 11]  0.7 [0.3; 2.4]  2.8 [0.5; 17]  1.0 [0; 4.4] 
Elderly  2.0 [0.2; 3.5]  0.5 [0.1; 0.9]  0.5 [0; 5.4]  0 [0; 0.8] 
Very elderly  1.4 [0.3; 3.1]  0.5 [0.1; 0.7]  0.9 [0; 2.3]  0 [0; 1.5] 
    ZON     
Infants  -
(b) [0; 18]  -
(b) [0; 2.3]  19  3.1 
Toddlers  14 [6.4; 32]  4.1 [1.9; 15]  39 [14; 60]  12 [0; 34] 
Other children  27 [11; 70]  11 [4.3; 32]  49 [15; 83]  22 [8.4; 56] 
Adolescents  30 [6.6; 70]  13 [3.6; 42]  54 [0; 79]  31 [0.9; 57] 
Adults  22 [4.6; 47]  7.2 [2.3; 18]  43 [5.7; 73]  12 [3.1; 40] 
Elderly  10 [1.9; 36]  3.0 [0.5; 8.6]  16 [2.1; 58]  8.9 [0; 34] 
Very elderly  11 [2.3; 27]  3.8 [0.6; 6.2]  19 [0; 58]  7.4 [0; 16] 
  LB: lower bound; UB: upper bound; P95: 95
th percentile.  
(a):  Percentage  difference,  determined  for  each  [age  group  x  survey]  combination,  as  the  difference  between  the 
mean/95
th percentile obtained with scenario B and the mean/95
th percentile obtained with scenario A divided by the 
mean/95
th percentile obtained with scenario A, and presented for each age class as the median [minimum; maximum] 
across the surveys. When the median, minimum and maximum are equal, only one value is given.  
(b):  the median is not indicated as there are only two surveys for this age group.  
Note: In order to avoid the impression of too high precision, the percentages are rounded to 2 figures.  
 
 
   Maximum levels deoxynivalenol, fumonisins, zearalenone 
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5.3.  Impact on acute exposure levels to DON 
5.3.1.  Methodology  
The impact of the tMLs on acute exposure levels to DON was also assessed, as a group ARfD  has 
been established as acute HBGV by JECFA for DON and its derivatives. Two scenarios of acute 
exposure  were  designed: a  first scenario  (scenario C)  at  the  ingredient  level  (maize  grain,  maize 
milling fractions with particle size > 500 µm, maize milling fractions with particle size ≤ 500 µm), and 
a  second  scenario  (scenario  D)  at  the  processed/composite  product  level  (maize-based  breakfast 
cereals, maize-based snacks, maize-based pastries). The acute exposure was assessed independently 
for each ingredient and processed/composite product considered.  
In  scenario  C,  the  ingredient  eaten  as  such  or  present  in  composite  products  during  a  day  was 
considered to contain DON at the level of the ML defined for the ingredient.  In scenario D,  the 
processed/composite product eaten during a day was considered to contain DON at the ML defined for 
the final processed/composite product. In a first sub-scenario (C.1 and D.1), the current ML was used 
whereas in a second sub-scenario (C.2 and D.2), the tML was considered. The other foods consumed 
during the same day were at the background DON levels (mean LB - UB level), as considered in the 
chronic exposure assessment. 
For each [survey x age group] combination and food considered, when more than 60 consumption 
days were available, the percentage of consumption days with exposure level above the group ARfD  
was estimated and compared between the two sub-scenarios.  
5.3.2.  Results of the impact on acute DON exposure levels 
  Maize grain for consumption and maize milling fractions 
Table 14 shows, for the three ingredients considered, the number of surveys in each age group found 
with at least one consumption day with exposure above the group ARfD and the range of percentage 
of days with exposure above the group ARfD estimated for both scenarios (C.1 and C.2).  
„Maize milling fractions ≤ 500 µm‟ were found with at least one consumption day above the group 
ARfD in 3 surveys (out of 46 surveys taken into account in the acute assessment) with scenario C.1 
(current  ML).  In  these  surveys,  the  percentage  of  consumption  days  above  the  group  ARfD  was 
estimated to be up to 0.2 %, and the highest acute exposure level at 16.6 µg/kg b.w. In scenario C.2, 
which was corresponding to the tML, the percentage of consumption days above the group ARfD was 
estimated to be up to 0.6 %, and the highest acute exposure level at 19.6 µg/kb b.w. Maximum levels deoxynivalenol, fumonisins, zearalenone 
 
EFSA Journal 2014;12(5):3699  37 
Table 14:  Acute exposure to DON estimated in scenario C expressed in µg/kg b.w. across surveys and age groups  
Food group  Age group  N
(a) 
Range of 
consumption 
days 
simulated
(b) 
Scenario C.1 
(Current ML) 
Scenario C.2 
(Suggested increased ML) 
Range of acute 
exposure levels
(c) 
N 
> acute 
HBGV
(d) 
Range of percentage 
days above acute 
HBGV
(e) 
Range of acute 
exposure levels
(c) 
N 
> acute 
HBGV
(d) 
Range of percentage 
days above acute 
HBGV
(e) 
Maize grain               
for 
consumption 
Other children  3  72 – 298  0.14 - 6.47  0  0  0.15 - 8.45  1  0.7 
Adolescents  2  146 - 181  0.12 - 5.67  0  0  0.15 - 6.99   0  0 
Adults  7  62 – 393  0.03 - 4.45  0  0  0.04 - 5.80   0  0 
Maize milling 
fractions                    
≤ 500 µm 
Toddlers  3  63 – 250  0.06 - 6.12  0   0  0.06 - 7.08  0  0 
Other children  12  61 – 700  < 0.005 - 16.6  3  0.1 - 0.2  < 0.005 - 19.6  3  0.1 - 0.6 
Adolescents  8  63 - 1199  < 0.005 - 4.49  0  0  < 0.005 - 5.31   0  0 
Adults  16  70 - 2719  < 0.005 - 3.75  0  0  < 0.005 - 4.48   0  0 
Elderly  4  131 - 364  < 0.005 - 1.85  0  0  < 0.005 - 1.94   0  0 
Very elderly  3  62 – 165  0.03 - 1.41  0  0  0.03 - 1.64   0  0 
Maize milling 
fractions                      
> 500 µm 
Toddlers  3  86 – 277  0.21 - 6.37  0  0  0.21 - 8.37  1  0.8 
Other children  11  81 - 1247  0.02 - 12.4  1  0.1  0.03 - 16.4  3  0.1 - 0.5 
Adolescents  7  87 – 986  0.04 - 7.96  0  0  0.04 - 10.5  1  0.2 
Adults  16  62 - 3283  0.01 - 5.08  0  0  0.01 - 6.61  0  0 
Elderly  2  291 - 353  0.01 - 1.13  0  0  0.02 - 1.40  0   0 
Very elderly  1  81  0.06 - 1.65  0  0  0.06 - 1.79  0  0 
(a):  number of surveys with at least 60 consumption days available for the corresponding food product and taken into account in the acute exposure assessment.  
(b):   minimum and maximum number of consumption days available across surveys taken into account for the acute exposure assessment. When the minimum and the maximum are equal, only 
one value is given.  
(c):    minimum and maximum upper bound acute exposure levels estimated across the surveys taken into account for the acute exposure assessment.  
(d):  number of surveys with at least one consumption day above the acute HBGV.  
(e):  minimum and maximum percentage of consumption days above the acute HBGV for the surveys with at least one consumption day above the acute HBGV. When the minimum and the 
maximum are equal, only one value is given.  
Note: In order to avoid the impression of too high precision, the numbers for exposure estimates are rounded to 3 figures, and the percentages to 2 figures.  Maximum levels deoxynivalenol, fumonisins, zearalenone 
 
EFSA Journal 2014;12(5):3699  38 
„Maize milling fractions > 500 µm‟ were found with at least one consumption day above the acute 
HBGV (group ARfD)  in only 1 survey (out of 40 surveys taken into account in the acute assessment) 
with scenario C.1 (current ML). In this survey, the percentage of consumption days above the group 
ARfD was estimated at 0.1 % and the highest acute exposure level at 12.4 µg/kg b.w. In scenario C.2, 
which was corresponding to the tML, five surveys were found with at least one consumption day 
above the group ARfD, with a percentage of consumption days above the group ARfD estimated up to 
0.8 % and the highest acute exposure level at 16.4 µg/kg b.w.   
Whereas „Maize grain for consumption‟ was not associated with any consumption  day above the 
group ARfD in scenario C.1 (current ML), it was associated with 0.7 % consumption days above the 
group ARfD in one survey out of the 12 considered in scenario C.2 (tML). The highest acute exposure 
level was estimated at 8.45 µg/kg b.w.   
  Maize-based processed/composite products 
Table  15  shows  the  results  obtained  from  the  acute  exposure  scenario  on  processed/composite 
products. 
„Maize-based breakfast cereals‟ were found with at least one consumption day above the group ARfD 
in 2 surveys (out of 39 surveys taken into account in the acute assessment) with scenario D.1 (current 
ML). In these surveys, the percentage of consumption days above the group ARfD was estimated to be 
up to 0.9 % and the highest acute exposure level estimated at 10.2 µg/kg b.w. Same percentage of 
consumption days above the group ARfD was estimated in scenario D.2 (tML), with the highest acute 
exposure level at 14.4 µg/kg b.w.  
„Maize-based  pastries‟  were  found  with  at  least  one  consumption  day  above  the  group  ARfD  in 
2 surveys (out of 28 surveys taken into account in the acute assessment) with scenario D.1 (current 
ML). In these surveys, the percentage of consumption days above the group ARfD was estimated up to 
1.2  %  and  the  highest  acute  exposure  level  at  14.0  µg/kg  b.w.  In  scenario  D.2,  which  was 
corresponding to the tML, 9 surveys were found with at least one consumption days above the group 
ARfD, with a percentage of consumption days above the group ARfD estimated up to 8.1 % and the 
highest acute exposure level estimated at 20.8 µg/kg b.w.  
Whereas „Maize-based snacks‟ were not associated with any consumption day above the group ARfD 
in scenario D.1 (current ML), it was associated with 0.2 % consumption days above the group ARfD 
in one survey out of the 12 surveys considered in scenario D.2 (tML). The highest acute exposure 
level was estimated at 9.40 µg/kg b.w.  Maximum levels deoxynivalenol, fumonisins, zearalenone 
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Table 15:  Acute exposure to DON estimated in scenario D expressed in µg/kg b.w. across surveys and age groups  
Food group  Age group  N
(a) 
Range of 
consumption 
days 
simulated
(b) 
Scenario D.1 
(Current ML) 
Scenario D.2 
(Suggested increased ML) 
Range                    
of acute 
exposure levels
(c) 
N 
> acute 
HBGV
(d) 
Range of percentage 
days above acute 
HBGV
(e) 
Range of acute 
exposure levels
(c) 
N 
> acute 
HBGV
(d) 
Range of 
percentage 
days above acute 
HBGV
(e) 
Maize-based 
breakfast 
cereals 
Toddlers  1  90  0.26 - 5.18  0   0  0.29 - 7.76  0  0 
Other children  10  95 - 1247  0.14 - 10.2  2  0.2 - 0.9  0.16 - 14.4  2  0.2 - 0.9 
Adolescents  8  64 - 986  0.07 - 5.41  0   0  0.08 - 7.96  0  0 
Adults  17  62 - 3282  0.02 - 4.11  0   0  0.03 - 6.04  0  0 
Elderly  2  291 - 350  0.07 - 4.73  0   0  0.10 - 6.93  0  0 
Very elderly  1  81  0.10 - 1.73  0   0  0.12 - 1.98  0  0 
Maize-based 
pastries 
Toddlers  1  130  1.35 - 7.79  0   0  1.88 - 10.7  1  4.6 
Other children  6  104 - 433  0.41 - 10.1  1  1.2  0.59 - 13.8  3  1.8 - 8.1 
Adolescents  6  65 - 741  0.14 - 14.0  1  0.7  0.22 - 20.8  2  1.2 - 2.4 
Adults  11  70 - 1603  0.10 - 6.37  0   0  0.13 - 9.37  3  0.1 - 0.6 
Elderly  3  100 - 202  0.17 - 4.47  0   0  0.21 - 6.62  0  0 
Very elderly  1  130  0.24 - 2.77  0   0  0.32 - 4.08  0  0 
Maize-based 
snacks 
Toddlers  1  127  0.61 - 5.37  0   0  0.65 - 7.87  0  0 
Other children  3  99 - 414  0.14 - 7.05  0   0  0.15 - 9.40  1  0.2 
Adolescents  2  146 - 234  0.12 - 3.32  0   0  0.15 - 4.08  0  0 
Adults  6  89 - 393  0.03 - 5.08  0   0  0.04 - 6.62  0  0 
(a):  number of surveys with at least 60 consumption days available for the corresponding food product and taken into account in the acute exposure assessment.  
(b):  minimum and maximum number of consumption days available across surveys taken into account for the acute exposure assessment. When the minimum and the maximum are equal, only 
one value is given.  
(c): minimum and maximum upper bound acute exposure levels estimated across the surveys taken into account for the acute exposure assessment.  
(d):  number of surveys with at least one consumption day above the acute HBGV.  
(e):  minimum and maximum percentage of consumption days above the acute HBGV for the surveys with at least one consumption day above the acute HBGV. When the minimum and the 
maximum are equal, only one value is given.  
Note: In order to avoid the impression of too high precision, the numbers for exposure estimates are rounded to 3 figures, and the percentages to 2 figures. 
 Maximum levels deoxynivalenol, fumonisins, zearalenone 
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6.  Risk characterization 
6.1.  Deoxynivalenol 
 
The group PMTDI of 1 μg/kg b.w. per day and the group ARfD of 8 μg/kg b.w., established by 
JECFA  (FAO/WHO,  2011),  includes  the  acetyl-derivatives  3-Ac-DON  and  15-Ac-DON.  The 
exposure from the acetyl-derivatives has not partially taken into account in this statement. Indeed, 
whereas ELISA results available for maize and maize-based products include the DON derivatives, the 
results considered for the other foods, generated by gas and liquid chromatography, were exclusively 
referring to the parent DON compounds.  
Acute and chronic exposure calculations for the different age groups have been carried out to estimate 
the impact of temporary increase of the ML for DON in:  
i)  unprocessed maize with the exception of unprocessed maize intended to be processed by 
wet milling, from  750 to 2250 µg/kg,   
ii)  milling fractions of maize with a particle size of less than or equal to 500 microns from 
200 to 300 µg/kg, 
iii)  milling fractions of maize with a particle size of more than 500 microns from 1250 to 
1500 µg/kg,  
iv)  maize and maize milling products intended for direct human consumption from 750 to 
1000 µg/kg,  
v)  maize-based breakfast cereals and maize-based snacks and maize-based foods for direct 
human consumption from 500 to 750 µg/kg. 
6.1.1.  Chronic risk characterisation 
Chronic exposure calculations for DON are presented and discussed in Section 5.2. Impact on chronic 
exposure  levels  to  DON,  FUMO  and  ZON  and  summarised  in  Table  10  of  that  section.  The 
exceedance of the group PMTDI is higher in „toddlers‟ than in the other age groups, ranging between 
5.4 and 52 % (minimum LB and maximum UB) when considering the specific contamination of the 
2013 maize grains harvest and implementation of current MLs. This is increased to between 6.1 and 
54 % when considering the chronic exposure reflecting the implementation of tML. 
Such results suggest a low impact of a temporary increase in MLs for chronic exposure levels in all 
age groups, which is explained by the fact that overall dietary DON exposure is mainly driven by 
foods other than maize-based products. However, application of both of current and increased MLs led 
to exposures in the region of the group PMTDI of 1 µg/kg b.w. per day in several age groups being 
highest in the ‟toddlers‟. It has to be noted that this group PMTDI is based on a NOEL for decreased 
body weight gain in mice upon chronic exposure, an endpoint particularly relevant for infants, toddlers 
children and adolescents age groups in growing life stages. Any exposures exceeding the PMTDI in 
these age groups are therefore of particular concern, as already pointed out in the earlier assessment on 
DON (EFSA CONTAM Panel, 2013).  
6.1.2.  Acute  risk characterisation 
Acute exposure scenarios addressed people who would consume maize grains, maize milling products, 
maize-based breakfast cereals, maize-based snacks and maize-based pastries containing DON equal to 
the ML. Results are presented and discussed in Section 5.3. Impact on acute exposure levels to DON 
are summarised in Tables 15 and 16 of that section.  
Such assessment resulted in a very low percentage of consumption days above the group ARfD (< 1%) 
for all products except the maize-based pastries, whatever the ML (current, tML) considered. Maximum levels deoxynivalenol, fumonisins, zearalenone 
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For maize-based pastries when applying the increased tMLs,  the probability of exceedance of the 
ARfD increased from 1.2 up to 8.1 % and from 0.7 up to 2.4 % of consumption days for the „other 
children‟  and „adolescents‟ age groups, respectively. The highest acute exposure level resulting from 
the consumption of maize-based pastries at the ML was observed in the „adolescents‟ age group,  
estimated at 14.0 and 20.8 µg/kg b.w. with the current ML and tML, respectively. For toddlers, no 
exposure  days  above  the  ARfD  was  observed  when  considering  current  ML,  whereas  4.6  %  of 
consumption days were estimated to exceed the ARfD when considering the tML. These increased 
probabilities  indicate  a  potential  concern  resulting  from  the  consumption  of  maize-based  pastries 
containing high DON level for these age groups. 
6.2.  Fumonisins 
Since no recent risk assessment for fumonisins is available from EFSA, the HBGV derived from most 
recent comprehensive risk assessment for fumonisins carried out by the JECFA in 2011 (FAO/WHO, 
2012) have been considering in the present statement. JECFA has identified kidney and liver effects as 
crucial effects of fumonisin mediated toxicity and established a group PMTDI of 2 µg/kg b.w. per day 
as  HBGV.  It  has  to  be  noted  that the  mandate from  the  Commission  for the  present  assessment 
concerns FB1 and FB2. However, part of the occurrence data available the present assessment was 
covering the sum of FB1, FB2 and FB3. Taking into account that most toxicological assessments and 
also the PMTDI are derived mainly from data with FB1 and the structural similarities of the different 
fumonisin derivatives of relevance, this is considered acceptable.  
Chronic exposure calculations for the different age groups have been carried out to estimate the impact 
of temporary increase of the ML for FUMO in:  
i)  unprocessed maize,with the exception of unprocessed maize intended to be processed by 
wet milling, from  4000 to 4500 µg/kg,  
ii)  milling fractions of maize with a particle size of less than or equal to 500 microns from 
2000 to 3500 µg/kg,  
iii)  milling fractions of maize with a particle size of more than 500 microns from 1400 to 
1900 µg/kg, 
iv)  maize  intended  for  direct  human  consumption,  maize-based  foods  for  direct  human 
consumption with the exception of maize-based breakfast cereals and maize-based snacks 
from 1000 to 1500 µg/kg,  
v)  maize-based breakfast cereals and maize-based snacks from 800 to 1300 µg/kg.   
 
Chronic  exposure  calculations  for  FUMO  are  presented  and  discussed  in  Section  5.2.  Impact  on 
chronic exposure levels to DON, FUMO and ZON and summarised in Table 13 of that section. The 
exceedance  of  the  group  PMTDI  is  higher  in  „other  children‟  than  in  other  age  groups,  ranging 
between 0 and 25.3 % at the LB and between 0.1 and 47.2 % at the UB when considering the specific 
contamination of the 2013 maize grains harvest and implementation of current MLs. This is increased 
to between less than 0.1 % and 26 % at the LB and between 0.1 % and 47.6 % at the UB when 
considering the chronic exposure reflecting the implementation of tML. 
Overall, the results show that a temporary increase in MLs has a low impact on exposure levels and 
consequently on any risk estimates. However, when considering the current MLs, exposure levels of 
FUMO are already in the region of the group PMTDI of 2 µg/kg b.w. per day in several age groups, 
being highest for the ‟other children‟, and are therefore of health concern.  
6.3.  Zearalenone 
 
In its recent assessment (EFSA CONTAM Panel, 2011), the CONTAM Panel concluded that the most 
critical effect of zearalenone mediated toxicity are oestrogenic effects occurring already at low dose Maximum levels deoxynivalenol, fumonisins, zearalenone 
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levels and therefore the Panel established a TDI of only 0.25 µg/kg b.w. per day (or 250 ng/kg b.w. 
per day). The CONTAM Panel pointed out in their opinion that it is possible that elevated circulating 
levels of oestrogens could lead to adverse effects either from long term exposure or from short-term 
exposure during a sensitive stage of development.  
Chronic exposure calculations for the different age groups have been carried out to estimate the impact 
of temporary increase of the ML for ZON for:  
i)  unprocessed maize ,with the exception of unprocessed maize intended to be processed by 
wet milling, from 350 to 500 µg/kg; 
ii)  milling fractions of maize with a particle size of less than or equal to 500 microns from 
200 to 300 µg/kg; 
iii)  milling fractions of maize with a particle size of more than 500 microns from 300 to 
400 µg/kg; 
iv)  maize  intended  for  direct  human  consumption,  maize-based  foods  including  snacks,  
breakfast cereals and milling products for direct consumption from 100 to 200 µg/kg. 
Chronic exposure calculations for ZON are presented and discussed in Section 5.2. Impact on chronic 
exposure  levels  to  DON,  FUMO  and  ZON  and  summarised  in  Table  12  of  that  section.  The 
exceedance of the TDI is the higher in „toddlers‟ than in other age groups, ranging between 0 and 
9.2 % (minimum LB and maximum UB) when considering the specific contamination of the 2013 
maize grains harvest and implementation of current MLs. This is increased to between less than 0.1 % 
and 9.8 % when considering the chronic exposure reflecting the implementation of tML. 
Increasing the tMLs for ZON in maize and maize-based products will also lead to a more pronounced 
increase in overall dietary ZON exposure (as compared to DON and FUMO) since maize and maize-
based products are the main contributors to total ZON exposure. High exposure levels for ZON both 
with  current  and increased  ML  levels  are  around  or  above  the TDI  for  the age  groups  „infants‟, 
„toddlers‟ and „other children‟ at the upper bound estimate and thus might be considered as being a 
health concern. The CONTAM Panel pointed out that it is possible that elevated circulating levels of 
oestrogens could lead to adverse effects either from long term exposure, but also from short-term 
exposure to ZON during a sensitive stage of development. Thus, the impact of the proposed temporary 
increases in MLs for ZON need to be considered also in the light of these conclusions.  
6.4.  Risk consideration of individuals suffering from coeliac disease 
Coeliac disease is provoked by an immune reaction to food containing gluten. The prevalence of 
coeliac disease in Europe is estimated to be 1.0 % (95% CI 0.9 – 1.1) (Mustalahti et al., 2010). The 
management of the disease consists in a gluten-free diet. Maize is among the cereals – together with 
rice,  buckwheat  and  millet  –  which  do  not  contain  gluten.  Consequently,  subjects suffering  from 
coeliac disease may consume higher levels of maize grain and maize-based products than the general 
population. There is no survey on the specific consumption habits of subjects suffering from ceoliac 
disease available for risk assessment in EFSA. However, people suffering from coeliac disease are 
considered to be represented in the Comprehensive database according to the prevalence of disease. In 
addition, the Comprehensive database covers a wide range of individual consumption patterns, which 
are taken into account when assessing the exposure levels of the European population. Thus, it is 
considered that those subjects suffering from coeliac disease who choose to preferably consume maize 
grains and maize-based products are represented by the high consumers of maize and maize-based 
products.  The  exposure  levels  of  these  subjects  can  be  approached  by  the  high  exposure  levels 
(95
th percentile) estimated for the general population. At the current MLs, 95
th percentile of exposure 
levels above the respective chronic HBGVs were estimated for DON and FUMO for some surveys in 
the younger age groups (infants, toddlers, other children and adolescents) for both the LB and UB. 
Regarding ZON, the LB estimates of the 95
th percentile of exposure were below the chronic HBGV in 
all surveys and age groups whereas the UB exposure estimates were above the HBGV in some surveys Maximum levels deoxynivalenol, fumonisins, zearalenone 
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in the infants and toddlers age groups. At the tML, the 95
th percentile of exposures were increased by 
up to 20, 17 and 83 % for DON, FUMO and ZON respectively. The age groups with at least one 
survey with a 95
th percentile above the chronic HBGV remain the same. For ZON, an additional age 
group appears with a least one survey with a UB 95
th percentile above the HBGV: the other children.  
7.  Uncertainty analysis 
The evaluation of the inherent uncertainties in the assessment of exposure to DON has been performed 
following the guidance of the Opinion of the Scientific Committee related to Uncertainties in Dietary 
Exposure Assessment (EFSA, 2006). In addition, the report on „Characterizing and Communicating 
Uncertainty  in  Exposure  Assessment‟  has  been  considered  (WHO/IPCS,  2008).  According  to  the 
guidance provided by the EFSA opinion (2006) the following sources of uncertainties have been 
considered: assessment objectives, model input (parameters) and exposure scenarios/model. 
7.1.  Assessment objectives 
The objectives of the assessment were clearly specified in the terms of reference. 
7.2.  Model input (parameters) 
The impact of the tMLs was assessed considering the results from FranceAgriMer collector survey, 
the  only  source  of  information  considered  suitable  for  such  assessment.  This  survey  provides  a 
representative overview of DON, FUMO and ZON in the 2013 French maize grains harvest, which 
represents around 25 % of the maize grains produced in the European Union. In this assessment, it was 
assumed that such data are also representative of maize grains at the European level. However, results 
from the Euromaisiers data, which provide a better overview at European level, showed higher DON 
and FUMO levels and lower ZON levels in maize grains than those observed in the FranceAgriMer 
survey. Such differences may be explained by differences in the analytical techniques used. They can 
also reveal a variability of contamination of maize grains used for food processing at the European 
level, which come not only from France but also from other European and non European countries, 
which are not covered by the FranceAgriMer survey. As a consequence, the impact of tML on DON, 
FUMO and ZON occurrence and exposure levels at the European level may have been under or over 
estimated. 
In order to assess the impact of tML in maize milling products, transfer rates from grains to milling 
products were used, set at the ratio between the tML defined for maize milling products and one 
defined for unprocessed maize grain. Such transfer rates are considered to reflect average transfer 
observed in maize milling products made from the 2013 maize grains harvest. However, according to 
information provided by the requestor, high variability was observed regarding the transfer of DON 
and FUMO from grains to grain milling products with particle size below 500 µm, from 0.25 to 1.1 for 
DON and from 0.7 to 1.4 for FUMO. Considering on a worst case basis a transfer rate of 1.1 for DON 
and 1.4 for FUMO in grain milling products with particle size below 500 µm, the average level in 
DON and FUMO in grain milling products would be around 10 % higher and exposure levels up to 
4 % higher when considering current ML than occurrence and exposure levels estimated with the 
average transfer rates considered in this assessment. 
In order to assess the impact of tML in maize-based products, it was assumed that other ingredients 
composing  the  products  were  not  containing  DON,  FUMO  and  ZON.  This  may  have  lead  to  an 
underestimation of the occurrence and exposure levels. Any processing effect on DON, FUMO and 
ZON levels was also not considered. According to previous statements (EFSA CONTAM Panel, 2011, 
2013), DON and ZON were found to be quite stable during cooking. However, extrusion cooking 
would  decrease  ZON  levels.  As  a  consequence,  the  impact  of  tML  on  DON,  FUMO  and  ZON 
occurrence in maize-based products may have been over estimated. 
DON and FUMO levels considered in the present statement were originating from different analytical 
techniques  (ELISA  and  HPLC).  On  one  hand,  results  from  ELISA  cover  compounds  (DON Maximum levels deoxynivalenol, fumonisins, zearalenone 
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derivatives, FB3) which are not included in the current definition of the ML, leading to a potential 
overestimation of the non-compliance rates in maize and maize-based products and bias in the impact 
of tML on occurrence and exposure levels. On the other hand, results from HPLC cover the parent 
DON compound and the sum of FB1 and FB2 only, which differs from the definition of the HBGVs 
considered in the present statement, leading to a potential underestimation of the risk of exposure.   
7.3.  Exposure model/exposure scenarios 
While assessing the impact of the current MLs and tMLs on occurrence and exposure levels, it was 
assumed that non compliant products would not be on the European market. This is considered to be 
an optimistic scenario, which may have lead to potential underestimation of occurrence and exposure 
levels. 
The impact of the tMLs on occurrence and exposure levels has been assessed independently for the 
three mycotoxins, without considering potential correlations (positive or negative) between them. The 
effect of potential correlations was roughly assessed considering the data from FranceAgriMer survey, 
which provided results for all three mycotoxins in each sample. The average occurrence level in grains 
and grains milling products were estimated after the exclusion of samples non compliant for at least 
one out of the three mycotoxins. This analysis revealed that average levels in maize grains and milling 
products estimated independently for each mycotoxin after the exclusion of samples non compliant to 
the current level were around 5 - 6 %, 26 - 41 % and 7 - 8 % higher than the average levels estimated 
considering the correlations between the mycotoxins, for DON, FUMO and ZON respectively. The 
impact of tMLs on DON and ZON levels were in the same ranges considering or not the correlations 
between  the  three  mycotoxins.  It  was  higher  for  FUMO,  estimated  at  41  –  65  %  increase  when 
considering  the correlations  between the three  mycotoxins  compared  to  7  –  23  %  increase  when 
assessed independently.    
In  both  chronic  and  acute  exposure  assessments,  two  extreme  scenarios  (LB  –  UB)  were  made 
regarding  the  results  below  the  LOD/LOQ.  True  exposure  levels  are  considered  to  be  comprised 
between the LB and UB estimates provided. Big differences between the LB and UB estimates were 
observed for ZON, due to high LOQs associated with censored data.  
In the acute exposure scenario done at the ingredients level, it was assumed that all the maize grains or 
maize milling products present in all maize-based foods consumed during the same day contain DON 
at the current ML and tML. This scenario is considered as a worst-case scenario, as processed maize-
based products such as maize-based breakfast cereals or snacks are most often bought as such and the 
probability that their ingredients are simultaneously at a level equal to the ML is low.  
In the acute exposure scenario done at the processed maize-based products level, each kind of maize-
based products was considered independently. This scenario may underestimate some situations of 
high exposure resulting from the consumption of several products simultaneously containing high 
DON concentrations. However, in the recent EFSA report on DON in food and feed, it was shown that 
in  most  cases  the  events  of  DON  acute  exposure  above  the  group  ARfD  were  explained  by  the 
consumption of one single food.  
In all exposure scenarios, it was considered that sweet corn, maize oil, maize syrup, as well as foods 
for infants and young children and some alcoholic beverages made from maize grains would not be 
impacted by the higher levels of DON, FUMO and ZON observed in the 2013 maize grain harvest. 
This may have lead to an underestimation of the total exposure levels. 
A number of food groups (products of animal origin, starchy roots and tubers, fruits, nuts and oilseeds, 
vegetables  (sweet  corn  excepted),  beverages  (beer  excepted),  animal  and  vegetable  oils  and  fats 
(vegetable oil excepted), herbs spices and condiments, sugar and confectionary, juice and herbal tea 
for infants and young children, composite dishes other than cereal, rice and vegetable based, desserts) 
have not been taken into account in the exposure assessments. However, the contribution of such food 
groups to the total DON, ZON and FUMO exposure is expected to be low. Maximum levels deoxynivalenol, fumonisins, zearalenone 
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Subjects  suffering  from  coeliac  disease  can  be  considered  as  specific  population  group  due  to 
potentially high consumption habits of maize and maize-based products. Risk of exposure could not be 
specifically characterized for this population group, but was approached considering high exposure 
levels (95
th percentile) estimated in the general population. Considering the low prevalence of coeliac 
disease in the general population – at 1 % – the 95
th percentile of exposure of the general population 
may provide an underestimation of the high exposure levels that may be observed in this population 
group. 
7.4.  Other uncertainties 
Overall, all the uncertainties identified in previous assessments of DON, FUMO and ZEA (EFSA, 
CONTAM Panel, 2011; FAO/WHO, 2011, 2012,) as regards toxicity assessment  are also applicable 
for the present statement and are therefore not repeated here. An additional uncertainty for the present 
assessment results from the fact that calculations have been carried out for chronic i.e. lifelong daily 
exposure while possibly increased exposures (due to a temporary increase are only to be expected for a 
short period (i.e. until end of 2014). 
7.5.   Summary of uncertainties 
In Table 16, a summary of the uncertainty evaluation is presented, highlighting the main sources of 
uncertainty and indicating an estimate of whether the respective source of uncertainty might have led 
to an over- or underestimation of the exposure or the resulting risk. 
Table 16:  Summary of qualitative evaluation of the impact of uncertainties on the risk assessment of 
the dietary exposure to DON, FUMO and ZON 
Source of uncertainty 
Direction of uncertainty
(a) 
DON  FUMO  ZON 
Calculations  have  been  carried  out  for  chronic  i.e.  lifelong 
daily  exposure  while  increased  exposures  are  only  to  be 
expected for a short period (i.e. until end of 2014) 
+  +  + 
Lack of representativeness of occurrence data for the European 
level  +/-  +/-  +/- 
Variability of transfer coefficient from maize grains to maize 
milling products not considered  +/-  +/-  +/- 
Correlation between DON, ZON and FUMO  levels in foods 
not considered  +/-  +/-  +/- 
Influence of food processing on DON, ZON, FUMO stability 
not considered  +  +  + 
Broad range of LOQs, especially for ZON  -  -  + 
Use of LB data in the chronic exposure assessment  -  -  - 
Use of UB data in the chronic exposure assessment  +  +  + 
Use of UB background levels in the acute exposure assessment  +  N.A  N.A 
Heterogeneity  of  the  data  regarding  D ON  derivatives  and 
conjugates and FUMO compounds to exposure   +/-  +/-  N.A 
Subjects suffering from c oeliac disease not considered as a 
specific population group   -  -  - 
(a):  +  =  uncertainty  with  potential  to  cause  over-estimation  of  exposure/risk;  -  =  uncertainty  with  potential  to  cause 
underestimation of exposure/risk; N.A. = not applicable 
 
The impact of the uncertainties on the assessment of the risk for public health related specifically to a 
potential temporary derogation from the maximum levels of DON, ZON and FUMO for maize and 
maize products is substantial.  Maximum levels deoxynivalenol, fumonisins, zearalenone 
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CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
Impact of the tMLs on the occurrence levels and dietary exposure 
  Occurrence data on deoxynivalenol (DON), zearalenone (ZON) and fumonisins (FUMO) in 
maize  grains  and  maize  milling  products  from  the  2013  harvest  originating  from  three 
different sources (FranceAgriMer collector survey, IRTAC Cereal Sanitary Monitoring Plan, 
and Euromaisiers) were provided with the request. Depending on the source, maize samples 
were taken at the maize collector and/or at maize milling factory. Data were mainly coming 
from  France.  DON,  ZON  and  FUMO  were  analysed  with  enzyme-linked  immunosorbent 
assays  (ELISA)  and  high-performance  liquid  chromatography  (HPLC). This  represented  a 
total of 2,637 analytical results. 
  Existing occurrence data on DON, ZON and FUMO compiled in previous risk assessments 
conducted by the European Food Safety Authority (EFSA) and by the Joint FAO/WHO Expert 
Committee on Food Additives and Contaminants (JECFA) were also considered. These were 
mainly  corresponding  to  results  from  official  monitoring  programmes,  collected  over  a 
5 - 10 years period between 2000 and 2012, and reported by up to 21 European countries. This 
represented a total of 39,202 analytical results. 
  Mean DON, ZON and FUMO levels in maize grains and maize milling products estimated 
from the datasets provided with the request appeared to be 1.3 to 6 times higher compared to 
mean levels considered in previous assessments.  
  The impact of a temporary derogation from the maximum levels (tMLs) of DON, ZON and 
FUMO for maize and maize products was assessed considering the data from FranceAgriMer 
survey  which  was  the  most  suitable  source  of  information  for  such  assessment.  This 
represented a total of 663 analytical results, 221 results for each deoxynivalenol. Transfer rates 
from grain to grain milling products were assumed to correspond to the ratio between the tML 
defined in the grain milling products and the tML defined for the unprocessed grains. 
  Compared to the current MLs, it was estimated that the tMLs would increase mean MB levels 
of DON, ZON and FUMO in unprocessed maize grains and milling fractions by 16 – 18 %, 
25 – 27 % and 7.6 – 23 % respectively. Depending on the kind of ingredient and its percentage 
content in final processed/composite products, the mean middle bound (MB) levels of DON 
and FUMO in final processed/composite products were increased by 12 – 58 %, whereas mean 
MB levels of ZON were increased by 25 – 99 %. 
  The chronic dietary exposure to DON of children age groups („infants‟, „toddlers‟ and „other 
children‟) estimated with occurrence data reflecting current MLs ranged on average between 
0.22  and  1.11  µg/kg  body  weight  (b.w.)  per  day  (minimum  lower  bound  (LB)-maximum 
upper bound (UB)) and at the 95
th percentile between 0.94 and 2.10 µg/kg b.w. per day. The 
chronic dietary exposure to DON of the adult age groups (adolescents, adults, elderly and very 
elderly) ranged on average between 0.18 and 0.56 µg/kg b.w. per day and at the 95
th percentile 
between 0.38 and 1.01 µg/kg b.w. per day.  
  Depending on the survey and age group, the mean and 95
th percentile chronic dietary exposure 
to DON estimated with the occurrence data reflecting tML were up to 20 % higher than the 
levels estimated with the occurrence data reflecting current ML. Maximum levels deoxynivalenol, fumonisins, zearalenone 
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  The chronic dietary exposure to ZON of children age groups estimated with occurrence data 
reflecting current MLs ranged on average between 9.7 and 118 ng/kg b.w. per day (minimum 
LB-maximum UB) and at the 95
th percentile between 47 and 303 ng/kg b.w. per day. The 
chronic dietary exposure to ZON of the adult age groups ranged on average between 4.4 and 
64 ng/kg b.w. per day and at the 95
th percentile between 11 and 117 ng/kg b.w. per day. 
  Depending on the survey and age group, the mean and 95
th percentile chronic dietary exposure 
to ZON estimated with the occurrence data reflecting tML were up to 83 % higher than the 
levels estimated with the occurrence data reflecting current ML. 
  The chronic dietary exposure to FUMO of children age groups estimated with occurrence data 
reflecting  current  MLs  ranged  on  average  between  0.17  and  2.11  µg/kg  b.w.  per  day 
(minimum LB-maximum UB) and at the 95
th percentile between 0.54 and 4.39 µg/kg b.w. per 
day.  The  chronic  dietary  exposure  to  FUMO  of  the  adult  age  groups  ranged  on  average 
between  0.03  and  1.19  µg/kg  b.w.  per  day  and  at  the  95
th  percentile  between  0.08  and 
2.30 µg/kg b.w. per day. 
  Depending on the survey and age group, the mean and 95
th percentile chronic dietary exposure 
to FUMO estimated with the occurrence data reflecting tML were up to 17 % higher than the 
levels estimated with the occurrence data reflecting current ML. 
  Acute exposure scenarios addressed people who would consume maize grains, maize milling 
products,  maize-based  breakfast  cereals,  maize-based  snacks  and  maize-based  pastries 
containing  DON  equal  to the ML.  Such  assessment  resulted in  a  very  low  percentage of 
consumption  days  above  the  group  acute  reference  dose  (ARfD)  (<  1%)  for  all  products 
except the maize-based pastries, whatever the ML (current, tML) considered. For maize-based 
pastries, percentage of consumption days above the group ARfD estimated up to 1.2 % with 
the  current  ML  was  increased  up to  8.1  %  considering  the  tML,  with  a  maximum  acute 
exposure level estimated at 20.8 µg/kg b.w.  
Risk characterisation  
  The exceedance of the group PMTDI (provisional maximum tolerable daily intake) for DON 
is  higher  in  the  children  than  in  the  adults  age  groups,  ranging  between  2.7  and  52 % 
(minimum LB to maximum UB) when considering the current MLs. When considering the 
tMLs, this is slightly increased and estimated to range between 4.2 and 54 %. 
  The  results  obtained  suggest  a  low  impact  of  a  temporary  increase  in  MLs  for  chronic 
exposure levels of DON in all age groups which is explained by the fact that overall dietary 
DON  exposure  is  mainly  driven  by  foods  other  than  maize-based  ones.  However,  both 
application of current and increased MLs lead to average exposures in the region of the group 
PMTDI of 1 µg/kg b.w. per day especially in the „toddlers‟ age group. 
  The percentage of consumption days above the group ARfD estimated up to 1.2 and 8.1 % 
with the current MLs and tMLs, respectively, indicates a potential concern resulting from the 
consumption of maize-based pastries containing high DON level for the children age groups. 
  Although the mandate from the Commission for the present assessment concerns FB1 and FB2, 
based on the occurrence data available the present assessment was based on total fumonisin 
occurrence data. Taking into account that most toxicological assessments and also the PMTDI 
are derived mainly from data with FB1 and the structural similarities of the different fumonisin 
derivatives of relevance, this is considered acceptable.  
  The exceedance of the PMTDI defined for FUMO is the higher in the children than in the 
„adults‟ age  groups, ranging  between  0  and  47 %  (minimum  LB  to  maximum  UB)  when Maximum levels deoxynivalenol, fumonisins, zearalenone 
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considering current ML. When considering tML, this is slightly increased and estimated to 
range between less than 0.1 % and 48 %. 
  Results show that a temporary increase in MLs has only a very minor impact on exposure 
levels of FUMO and consequently on any risk estimates. However, when applying the current 
MLs, the exposure levels of FUMO are already in the region of the PMTDI of 2 µg/kg b.w. 
per day in several age groups, being highest in „other children‟ age group.   
  The exceedance of the TDI for ZON is the higher in the children than in the adults age groups, 
ranging between 0 and 9.2 % (minimum LB to maximum UB) when considering the current 
MLs. When considering the tMLs, this is slightly increased and estimated to range between 0 
and 9.8 %. 
  Exposure levels for ZON both with current and increased ML levels are around or above the 
TDI for the age groups of infants, toddlers and other children and thus might be considered as 
being  a  health  concern.  It  is  also  important  to  add,  in  the  context  of this  statement,  that 
although no acute reference value has been derived for ZON in a previous assessment (EFSA 
CONTAM Panel, 2011) it is possible that elevated circulating levels of oestrogens could lead 
to adverse effects either from long term exposure but also from short-term exposure during a 
sensitive  stage  of  development.  The  impact  of  the  increased  ML  for  ZON  needs  to  be 
considered in the light of these conclusions.  
  It was assumed that increased exposure of individuals suffering from coeliac disease due to a 
temporary increase of MLs for DON, FUMO and ZON for maize and maize products were 
reflected in the high exposure levels (95
th percentile) estimated for the general population.  
RECOMMENDATIONS 
  There is a need to better assess the DON, ZON and FUMO levels in maize grains and maize 
milling products from the 2013 harvest coming from other countries than France and used for 
food processing at the European level. 
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Appendix A: Mean levels of DON, ZON and FUMO reported in previous assessments in other 
foods than maize-based ones  
Table A1:  Grains and grain-based products 
Foodex 
level  Food groups 
Concentration LB – UB (µg/kg) 
DON  ZON  FUMO 
 
Grains for human consumption 
      4  Wheat germ  410  2.4 - 5.4  11.0 - 39.5 
4  Wheat grain, Durum  319 - 351  2.4 - 5.4  11.0 - 39.5 
4  Wheat grain, soft  137  2.4 - 5.4  11.0 - 39.5 
4  Bulgur wheat  0 - 15.5  2.4 - 5.4  18.5 - 146 
4  Wheat grain, unspecified  197  2.4 - 5.4  11.0 - 39.5 
3  Barley grain  27.8 - 73.2  2.6 - 5.6  18.5 - 146 
3  Rye grain  17.9 - 58.4  0.7 - 3.4  28.1 - 66.4 
3  Spelt grain  14.4 - 51.6  0.3 - 3.5  18.5 - 146 
3  Oats, grain  256  2.0 - 3.7  18.5 - 146 
3  Rice  14.4 - 51.6  3.8 - 9.7  0 - 115 
3  Other grains  14.4 - 51.6  0.9 - 3.4  18.5 - 146 
3  Grains for human consumption, unspecified  127 - 156  2.7 - 5.7  102 - 161 
 
Grain milling products 
      4  Wheat flour, brown  73.2  4.9 - 13  0 - 108 
4  Wheat flour, Durum  150  4.9 - 13  0 - 108 
4  Wheat flour, white  141  1.8 - 9.3  0 - 67.0 
4  Wheat flour, wholemeal  134  1.5 - 4.7  0 - 108 
4  Graham flour  71.7  4.9 - 13  0 - 108 
4  Wheat flour, gluten free  152  4.9 - 13  0 - 108 
4  Couscous  71.7  4.9 - 13  188 - 273 
4  Wheat bran  226  18 - 33  188 - 273 
4  Wheat groats  152  4.9 - 13  188 - 273 
4  Wheat semolina, Durum  330  0.1 - 3.0  188 - 273 
4  Wheat semolina, soft wheat  59.2 - 98.9  0.2 - 6.6  188 - 273 
4  Wheat starch  152  4.9 - 13  0 - 67.0 
4  Wheat milling products, unspecified  152  4.9 - 13  73.5 - 152 
3  Rye milling products  33.1 - 64.1  0.9 - 4.4  0 - 37.4 
3  Buckwheat milling products  6.7 - 55.3  0.4 - 3.5  71.9 - 120 
3  Oat milling products  74.8  2.9 - 9.0  71.9 - 120 
3  Rice milling products  79.3 - 108  2.8 - 10  71.9 - 120 
3  Spelt milling products  61.6 - 87.8  0.3 - 3.6  0 - 72.3 
3  Barley flour  22.2 - 34.2  2.8 - 10  71.9 - 120 
ahg 3  Other milling products   79.3 - 108  2.8 - 10  71.9 - 120 
3  Grain milling products, unspecified  125  5.4 - 12  279 - 315 
 
Bread and rolls 
      3  Wheat bread and rolls  83.1  0.2 - 4.7  0 - 132 
3  Rye bread and rolls  60.3  0.2 - 3.5  145 - 159 
3  Mixed wheat and rye bread and rolls  64.0  0.9 - 4.5  67.4 - 83.6 
3  Multigrain bread and rolls  81.3  0.6 - 4.1  112 - 199 
3  Unleavened bread, crisp bread and rusk  48.7  0.5 - 3.8  79.1 - 181 
3  Other bread  69.9  1.1 - 7.7  96.3 - 141 
3  Bread products  124  0.9 - 5.2  112 - 199 
3  Bread and rolls, unspecified  71.6  0.9 - 5.2  112 - 199 
 
Pasta 
      3  Glass noodle  109  0.6 - 5.8  137 - 201 
3  Noodle, rice  85.7 - 113  0.6 - 5.8  137 - 201 
ahg 3  Pasta and noodle, wheat flour  120  0.6 - 5.8  137 - 201 
3  Pasta, mixed cereal flour  85.7 - 113  0.6 - 5.8  137 - 201 Maximum levels deoxynivalenol, fumonisins, zearalenone 
 
EFSA Journal 2014;12(5):3699  52 
Table A1:  Continued 
Foodex 
level  Food groups  Concentration LB – UB (µg/kg) 
DON  ZON  FUMO 
3  Pasta, rye flour  109  0.6 - 5.8  137 - 201 
3  Pasta, spelt wholemeal  85.7 - 113  0.6 - 5.8  137 - 201 
ahg 3  Pasta, wheat wholemeal  49.3 - 94.6  0.6 - 5.8  137 - 201 
3  Pasta, gluten free  109  0.6 - 5.8  137 - 201 
3  Pasta (Raw), unspecified  109  0.6 - 5.8  137 - 201 
 
Breakfast cereals 
      4  Barley flakes  109 - 132  0.3 - 6.3  0 - 99.5 
4  Millet flakes  109 - 132  0.3 - 6.3  0 - 99.5 
4  Mixed cereal flakes  109 - 132  0.3 - 6.3  0 - 99.5 
ahg 4  Oat and oat bran flakes  132  0.5 - 3.1  9.30 - 95.1 
ahg 4  Rice flakes  109 - 132  0.3 - 6.3  22.5 - 133 
4  Spelt flakes  25.2 - 47.3  0 - 4.8  0 - 57.8 
ahg 4  Wheat and wheat germs flakes  95.3  8.4 - 23  18.1 - 143 
4  Cereal flakes, unspecified  84.9 - 115  2.2 - 10  36.4 - 80.9 
ahg 4  Rice, popped  40.8 - 92.4  0.3 - 6.3  22.5 - 133 
ahg 4  Wheat, popped  40.8 - 92.4  0.3 - 6.3  18.1 - 143 
4  Popped cereals, unspecified  40.8 - 92.4  0.3 - 6.3  41.0 - 84.8 
4  Barley grits  326 - 355  2.6 - 3.9  0 - 99.5 
4  Oat grits  326 - 355  2.6 - 3.9  9.30 - 95.1 
4  Rye grits  326 - 355  2.6 - 3.9  15.3 - 46.3 
4  Spelt grits  326 - 355  2.6 - 3.9  0 - 57.8 
4  Wheat grits  326 - 355  2.6 - 3.9  18.1 - 143 
4  Grits, unspecified  326 - 355  2.6 - 3.9  41.0 - 84.8 
4  Oat porridge  42.9 - 70.7  0.3 - 6.3  9.30 - 95.1 
4  Rice porridge  42.9 - 70.7  0.3 - 6.3  22.5 - 133 
4  Wheat semolina porridge  42.9 - 70.7  0.3 - 6.3  18.1 - 143 
4  Barley porridge  42.9 - 70.7  0.3 - 6.3  0 - 99.5 
4  Porridge, unspecified  42.9 - 70.7  0.3 - 6.3  41.0 - 84.8 
4  Breakfast cereals, unspecified  60.5 - 91.3  1.2 - 5.7  41.0 - 84.8 
 
Fine bakery wares 
      2  Pastries and cakes  81.6  1.4 - 4.8  109 - 164 
ahg 3  Biscuits, salty  120  5.8 - 9.0  114 - 162 
ahg 3  Biscuits, sweet  47.0  5.8 - 9.0  110 - 165 
3  Biscuits, unspecified  68.9  5.8 - 9.0  110 - 165 
2  Fine bakery wares, unspecified  72.7  4.2 - 7.7  109 - 164 
 
Other 
      2  Grains and grain-based products, unspecified  115  2.7  - 5.7  170- 215 
DON: deoxynivalenol; FUMO: fumonisins; LB: lower bound; UB: upper bound; ZON: zearalenone. Maximum levels deoxynivalenol, fumonisins, zearalenone 
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Table A2:  Other food groups  
Foodex 
level 
Food groups  Concentration LB – UB (µg/kg) 
DON  ZON  FUMO 
 
Vegetables and vegetable products 
      3  Sweet corn (Zea mays var. saccharata)  32.0 - 53.2  1.4 - 4.8  80.9 - 102 
Not taken into account in the exposure assessment: Vegetables and vegetable products other than sweet corn  
 
Legumes, nuts and oilseeds 
      2  Legumes, beans, dried  0 - 9.90  0  0 
Not taken into account in the exposure assessment: Legumes, nuts and oilseeds other than legumes, beans 
dried  
 
Animal and vegetable fats and oils 
      3  Corn oil  0  90  0 
3  Wheat germ oil  0  31 - 35  0 
ahg 3  Other vegetable oil  0  10 - 20  0 
3  Vegetable oil, unspecified  0  70 - 72  0 
Not taken into account in the exposure assessment: Animal and vegetable fats other than vegetable oils  
 
Alcoholic beverages 
      2  Beer and beer-like beverages  0  0.1 - 1.0  0 
Not taken into account in the exposure assessment: Alcoholic beverages other than beer and beer-like 
beverages  
 
Foods for infants and young children 
      2  Infant formulae, powder  0 - 26.3  0.3 - 8.2  0 
2  Infant formulae, liquid  0 - 3.30  0 - 0.9  0 
2  Follow-on formulae, powder  0 - 26.3  0.2 - 11  0 
2  Follow-on formulae, liquid  0 - 3.30  0 - 1.4  0 
3  Simple cereals which are or have to be reconstituted 
with milk or other appropriate nutritious liquids  10.0 - 45.6  0.2 - 6.0  1.00 - 205 
3 
Cereals with an added high protein food which are 
or have to be reconstituted with water or other 
protein-free liquid 
10.0 - 45.6  0.2 - 6.0  9.10 - 90.1 
3  Biscuits, rusks and cookies for children  10.0 - 45.6  0.2 - 6.0  3.40 - 92.5 
3  Pasta for children  10.0 - 45.6  0.2 - 6.0  2.90 - 98.1 
3  Cereal-based food for infants and young children, 
unspecified  10.0 - 45.6  0.2 - 6.0  2.90 - 98.1 
2  Ready-to-eat meal for infants and young 
children  2.80 - 40.6  0 - 5.5  0 
2  Yoghurt, cheese and milk-based dessert for 
infants and young children  0 - 25.6  0  0 
ahg 2  Food for infants and small children, unspecified  11.1 - 38.3  0.3 – 7.0  3.20 - 99.9 
Not taken into account in the exposure assessment: Fruit juice and herbal tea for infants and young children  
 
Products for special nutritional use 
      2  Food for weight reduction  0  1.5 - 4.2  0 
3  Fibre supplements  38.9 - 56.3  1.5 - 4.2  0 
ahg 3  Dietary supplements, other and unspecified  0  1.5 - 4.2  0 
2  Food for sports people (labelled as such)  0  1.5 - 4.2  0 
3  Fine bakery products for diabetics  38.9 - 56.3  1.5 - 4.2  0 
ahg 3  Dietetic food for diabetics, other and unspecified  0  1.5 - 4.2  0 
3  Nutritionally complete formulas  38.9 - 56.3  1.5 - 4.2  0 
3  Nutritionally incomplete formulas  38.9 - 56.3  1.5 - 4.2  0 
ahg 3  Medical food, other and unspecified  0  1.5 - 4.2  0 
ahg2  Products for special nutritional use, unspecified  38.9 - 56.3  1.5 - 4.2  0 
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Table A2:  Continued  
Foodex 
level 
Food groups  Concentration LB – UB (µg/kg) 
DON  ZON  FUMO 
 
Composite dishes 
      2  Cereal-based dishes  33.3  0  290 - 337 
2  Rice-based meals  33.3  0  0 
2  Vegetable-based meals  33.3  0  0 
2  Composite food, unspecified  33.3  0  290 - 337 
Not taken into account in the exposure assessment: Composite dishes other than cereal, rice and vegetable 
based  
 
Snacks, desserts and other foods 
      3  Potato crisps  86.1  2.6 - 12  0 
3  Pretzels  86.1  2.6 - 12  0 
3  Fish-based snacks  86.1  2.6 - 12  0 
3  Seafood chips  86.1  2.6 - 12  0 
ahg 3  Snack food, unspecified  110  2.6 - 12  52.6 - 163 
Not taken into account in the exposure assessment: Desserts, other foods  
 
Other food groups  
      Not taken into account in the exposure assessment: juice, water and non alcoholic beverages, eggs and egg 
products, fish and other seafood, fruit and fruit products, herbs, spices and condiments, meat and meat 
products, milk and dairy products, starchy roots and tubers, sugars and confectionery.  
DON: deoxynivalenol; FUMO: fumonisins; LB: lower bound; UB: upper bound; ZON: zearalenone. 
Note: In order to avoid the impression of too high precision, the numbers for occurrence values are rounded to 2 figures for 
ZON and 3 figures for DON and FUMO.  Maximum levels deoxynivalenol, fumonisins, zearalenone 
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Appendix B: Maize consumption habits in the European population  
Table B1: Overview on „Maize grain‟ consumption (g/day) by age group. Minimum, median and maximum of the mean and 95
th percentile values across 
European countries and dietary surveys are shown. 
  Infants  Toddlers  Other children  Adolescents  Adults  Elderly  Very elderly 
  All population (chronic exposure assessment) 
Average (g/day)               
Minimum   0  < 0.05  0.1  0.2  0.1  0  0 
Median  -
(a)  < 0.05  0.5  0.9  0.5  < 0.05  < 0.05 
Maximum  < 0.05  0.9  2.6  1.9  2.9  0.2  0.5 
95
th percentile (g/day) 
(b)               
Minimum   0  0  0  0  0  0  0 
Median  -
(a)  0  0  0  0  0  0 
Maximum  0  0  7.3  12  15  < 0.05  < 0.05 
  Consumption days (acute exposure assessment) 
Percentage of consumption days               
Minimum   0  0  0.1  0.3  0  0  0 
Median  -
(a)  0.7  1.3  1.8  0.5  < 0.05  0 
Maximum  0.1  2.9  5.8  4.5  7.5  0.3  1.3 
Average (g/day)               
Minimum   18  3.0  11  22  10  4.8  3.0 
Median  -
(a)  20  41  51  57  33  41 
Maximum  18  32  200  150  132  112  63 
95
th percentile (g/day) 
(b)               
Minimum   -
(b)  -
(b)  30  75  75  -
(b)  -
(b) 
Median  -
(a,b)  -
(b)  50  88  100  -
(b)  -
(b) 
Maximum  -
(b)  -
(b)  100  100  200  -
(b)  -
(b) 
 
(a):  no median value is derived as there are only two surveys available for the infants‟ age class. 
(b):  The 95
th percentile estimates obtained on dietary surveys/age classes with less than 60 observations may not be statistically robust (EFSA, 2011) and therefore they were not included in this 
table. 
Note: In order to avoid the impression of too high precision, the numbers for consumption values are rounded to 2 figures. A „0‟ indicates the absence of consumption. 
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Table B2:   Overview on „Maize milling fractions ≤ 500 µm‟ consumption (g/day) by age group. Minimum, median and maximum of the mean and 
95
th percentile values across European countries and dietary surveys are shown. 
  Infants  Toddlers  Other children  Adolescents  Adults  Elderly  Very elderly 
  All population (chronic exposure assessment) 
Average (g/day)               
Minimum   0  0.1  < 0.05  < 0.05  0.1  < 0.05  < 0.05 
Median  -
(a)  0.2  1.0  1.2  1.2  0.6  0.8 
Maximum  0.1  1.0  2.6  7.5  4.1  2.3  1.9 
95
th percentile (g/day)
(a)               
Minimum   0  0.4  0  0  0  0  0 
Median  -
(a)  3.7  4.8  6.0  6.1  3.2  7.9 
Maximum  0  5.2  12  40  24  17  9.9 
  Consumption days (acute exposure assessment) 
Percentage of consumption days               
Minimum   0  0.9  0.6  0.7  0  0.3  0.4 
Median  -
(a)  7.8  12  10  8.8  6.0  6.2 
Maximum  1.9  22  25  20  28  21  18 
Average (g/day)               
Minimum   4.5  2.7  2.5  3.5  2.7  3.0  0.1 
Median  -
(a)  5.1  8.5  11  13  11  10 
Maximum  4.5  16  20  39  44  26  31 
95
th percentile (g/day)
(a)               
Minimum   -
(b)  11  14  21  9.0  10  17 
Median  -
(a,b)  12  28  32  31  24  19 
Maximum  -
(b)  27  56  64  80  32  32 
 
(a):  no median value is derived as there are only two surveys available for the infants‟ age class. 
(b):  The 95
th percentile estimates obtained on dietary surveys/age classes with less than 60 observations may not be statistically robust (EFSA, 2011) and therefore they were not included in this 
table. 
Note: In order to avoid the impression of too high precision, the numbers for consumption values are rounded to 2. A „0‟ indicates the absence of consumption. 
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Table B3:  Overview on „Maize milling fractions > 500 µm‟ consumption (g/day) by age group. Minimum, median and maximum of the mean and 95
th 
percentile values across European countries and dietary surveys are shown. 
  Infants  Toddlers  Other children  Adolescents  Adults  Elderly  Very elderly 
  All population (chronic exposure assessment) 
Average (g/day)               
Minimum   0  0  < 0.05  < 0.05  0.2  < 0.05  0.1 
Median  -
(a)  0.5  2.0  1.6  1.1  0.3  0.4 
Maximum  0.5  3.4  10  17  6.6  2.5  1.8 
95
th percentile (g/day)
(a)               
Minimum   0  1.4  0  0  0  0  0 
Median  -
(a)  3.7  10  7.9  5.5  0  0 
Maximum  0  20  32  50  35  16  4.4 
  Consumption days (acute exposure assessment) 
Percentage of consumption days               
Minimum   0.0  0.0  0.3  0.5  0.6  0.2  0 
Median  -
(a)  7.5  11  7.3  4.7  2.6  2.2 
Maximum  3.0  19  36  34  19  14  17 
Average (g/day)               
Minimum   17  3.8  2.8  5.5  3.8  3.8  7.2 
Median  -
(a)  12  25  32  24  13  18 
Maximum  17  32  82  84  97  47  34 
95
th percentile (g/day)
 (a)               
Minimum   -
(b)  12  35  57  7.7  40  40 
Median  -
(a,b)  16  60  90  76  44  40 
Maximum  -
(b)  48  80  160  150  47  40 
 
(a):  no median value is derived as there are only two surveys available for the infants‟ age class. 
(b):  The 95
th percentile estimates obtained on dietary surveys/age classes with less than 60 observations may not be statistically robust (EFSA, 2011) and therefore they were not included in this 
table. 
Note: The In order to avoid the impression of too high precision, the numbers for consumption values are rounded to 2. A „0‟ indicates the absence of consumption. 
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Appendix C: Contribution of maize-based products to the total exposure to DON, FUMO and ZON 
 
Table C1:  Minimum and maximum relative contribution (%) of maize-based products to the DON total LB exposure  
Food category  Scenario  Infants  Toddlers  Other 
children  Adolescents  Adults  Elderly  Very 
elderly 
All maize-based products  Current ML  0 - 9.3  2 - 18  4.6 - 19  3.4 - 26  2.0 - 20  0.5 - 9.5  0.3 - 8.6 
  tML  0 - 11  2.6 - 21  6 - 26  4.8 - 34  2.8 - 26  0.6 - 11  0.5 - 9.8 
Maize grain for consumption  Current ML  0  0 - 0.3  0 - 1.1  0 - 1.3  0 - 6.2  0 - 0.2  0 - 0.9 
  tML  0  0 - 0.4  0 - 1.5  0 - 1.7  0 - 8.3  0 - 0.4  0 - 1.3 
Grain milling fractions ≤ 500 µm  Current ML  0 - 0.4  0 - 7.3  0 - 6.1  0 - 1.9  0 - 5.9  0 - 3.4  0 - 2.0 
  tML  0 - 0.5  0 - 8.2  0 - 6.8  0 - 2.2  0 - 6.7  0.1 - 3.9  0 - 2.2 
Grain milling fractions > 500 µm  Current ML  0  0 - 4.6  0 - 1.4  0 - 0.5  0 - 0.7  0 - 0.2  0 
  tML  0  0 - 5.3  0 - 1.6  0 - 0.5  0 - 0.8  0 - 0.3  0 
Maize-based breakfast cereal  Current ML  0 - 0.2  0 - 3.4  0 - 17  0 - 24  0.1 - 12  0 - 5.0  0.1 - 3.5 
  tML  0 - 0.3  0 - 5.0  0 - 22  0.1 - 31  0.1 - 17  0 - 7.0  0.2 - 4.9 
Maize-based pastries  Current ML  0 - 1.6  0 - 4.6  0 - 6.2  0 - 5.8  0 - 6.5  0 - 8.2  0 - 7.8 
  tML  0 - 1.9  0 - 5.1  0 - 7.0  0 - 6.6  0 - 7.4  0 - 9.4  0 - 8.9 
Maize-based snacks  Current ML  0 - 7.1  0 - 13  0.1 - 9.2  0.1 - 8.4  0.1 - 3.6  0 - 0.3  0 - 0.1 
  tML  0 - 8.7  0 - 15  0.1 - 11  0.2 - 12  0.2 - 5.3  0 - 0.5  0 - 0.1 
Maize bread  Current ML  0  0  0 - 0.1  0 - 0.1  0 - 1.6  0 - 0.3  0 
  tML  0  0  0 - 0.1  0 - 0.1  0 - 1.8  0 - 0.3  0 
Other maize-based foods  Current ML  0  0 - 1.6  0 - 1.6  0 - 0.2  0 - 0.3  0 - 0.7  0 - 0.7 
  tML  0  0 - 1.8  0 - 1.9  0 - 0.3  0 - 0.3  0 - 0.8  0 - 0.8 
 
Note: In order to avoid the impression of too high precision, the numbers for percentages are rounded to 2. A „0‟ indicates the absence of contribution to the total exposure. Maximum levels deoxynivalenol, fumonisins, zearalenone 
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Table C2:  Minimum and maximum relative contribution (%) of maize-based products to the FUMO total LB exposure  
 
Food category  Scenario  Infants  Toddlers  Other 
children  Adolescents  Adults  Elderly  Very 
elderly 
All maize-based products  Current ML  0 - 8.2  1.3 - 17  2.6 - 18  2.2 - 16  1.2 - 23  0.6 - 13  0.4 - 12 
  tML  0 - 9.8  1.9 - 21  4.0 - 22  3.1 - 24  1.7 - 30  0.8 - 16  0.7 - 15 
Maize grain for consumption  Current ML  0  0 - 0.2  0 - 1.2  0 - 0.7  0 - 5  0 - 0.2  0 - 0.8 
  tML  0  0 - 0.3  0 - 1.6  0 - 0.9  0 - 6.3  0 - 0.3  0 - 1.1 
Grain milling fractions ≤ 500 µm  Current ML  0 - 0.4  0 - 6.3  0 - 7.4  0 - 1.6  0 - 17  0 - 10  0 – 2.0 
  tML  0 - 0.5  0 - 7.8  0 - 8.9  0 - 1.9  0 - 21  0 - 13  0 - 2.4 
Grain milling fractions > 500 µm  Current ML  0  0 - 3.7  0 - 1.6  0 - 0.3  0 - 0.6  0 - 0.3  0 
  tML  0  0 - 4.1  0 - 1.7  0 - 0.4  0 - 0.7  0 - 0.3  0 
Maize-based breakfast cereal  Current ML  0 - 0.2  0 - 1.6  0 - 13  0 - 13  0.3 - 14  0.1 - 3.2  0.2 - 2.2 
  tML  0 - 0.3  0 - 2.5  0 - 19  0 - 21  0.3 - 20  0.1 - 4.9  0.2 - 3.5 
Maize-based pastries  Current ML  0 - 1.6  0 - 4.9  0 - 6.5  0 - 4.6  0 - 6.3  0 - 11  0 - 11 
  tML  0 - 2.0  0 - 6.0  0 - 7.8  0 - 5.6  0 - 7.8  0 - 14  0 - 14 
Maize-based snacks  Current ML  0 - 6.0  0 - 12  0.1 - 9.4  0.1 - 6.8  0.1 - 2.8  0 - 1.1  0 - 0.1 
  tML  0 - 7.1  0 - 14  0.1 - 11  0.1 - 9.3  0.1 - 3.7  0 - 1.8  0 - 0.1 
Maize bread  Current ML  0  0  0 - 0.1  0 - 0.1  0 - 1.5  0 - 0.3  0 
  tML  0  0  0 - 0.1  0 - 0.1  0 - 1.8  0 - 0.3  0 
Other maize-based foods  Current ML  0  0 - 0.9  0 - 0.9  0 - 0.2  0 - 0.2  0 - 0.8  0 - 0.8 
  tML  0  0 - 1.1  0 - 1.2  0 - 0.2  0 - 0.3  0 - 0.9  0 – 1.0 
 
Note: In order to avoid the impression of too high precision, the numbers for percentages are rounded to 2. A „0‟ indicates the absence of contribution to the total exposure. 
 
 
   Maximum levels deoxynivalenol, fumonisins, zearalenone 
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Table C3:  Minimum and maximum relative contribution (%) of maize-based products to the ZON total LB exposure  
Food category  Scenario  Infants  Toddlers  Other 
children  Adolescents  Adults  Elderly  Very 
elderly 
All maize-based products  Current ML  0 - 32  11 - 57  13 - 79  8.8 - 77  6.3 - 55  4.1 - 49  2.5 - 47 
  tML  0 – 42  17 - 67  22 - 87  14 - 87  11 - 70  5.9 - 62  4.7 - 54 
Maize grain for consumption  Current ML  0  0 - 0.5  0 - 2.8  0 - 3.1  0 - 13  0 - 1.0  0 - 3.3 
  tML  0  0 - 1.0  0 - 3.9  0 - 4.6  0 - 18  0 - 1.8  0 - 6.1 
Grain milling fractions ≤ 500 µm  Current ML  0 - 1.6  0 - 19  0 - 20  0 - 12  0 - 32  0.4 - 20  0 - 11 
  tML  0 - 1.7  0 - 22  0 - 21  0 - 12  0 - 35  0.5 – 23  0 - 13 
Grain milling fractions > 500 µm  Current ML  0  0 - 14  0 - 5.3  0 - 2.1  0 - 3.3  0 - 1.5  0 
  tML  0  0 - 16  0 - 5.5  0 - 2.3  0 - 3.7  0 - 1.8  0 
Maize-based breakfast cereal  Current ML  0 - 0.8  0 - 23  0.2 - 70  0.4 - 71  0.7 - 47  0.3 - 45  0.7 - 32 
  tML  0 - 1.2  0 - 30  0.2 - 78  0.4 - 79  0.8 - 60  0.3 - 59  0.8 - 45 
Maize-based pastries  Current ML  0 - 6.4  0 - 17  0 - 23  0 - 23  0 - 26  0 - 37  0 - 33 
  tML  0 - 6.8  0 - 16  0 - 23  0 - 24  0 - 29  0 - 42  0 - 37 
Maize-based snacks  Current ML  0 - 23  0 - 37  0.3 - 30  0.4 - 23  0.5 - 19  0 - 2.1  0 - 0.3 
  tML  0 - 32  0 - 48  0.5 - 39  0.6 - 30  0.8 - 30  0 - 3.8  0 - 0.4 
Maize bread  Current ML  0  0  0 - 0.8  0 - 0.4  0 - 10  0 - 1.3  0 
  tML  0  0  0 - 0.8  0 - 0.4  0 - 11  0 - 1.5  0 
Other maize-based foods  Current ML  0  0 - 9.6  0 - 10  0 - 1.1  0 - 1.7  0 - 4.6  0 - 4.8 
  tML  0  0 - 11  0 - 12  0 - 1.1  0 - 1.9  0 - 5.5  0 - 5.7 
Note: In order to avoid the impression of too high precision, the numbers for percentages are rounded to 2. A „0‟ indicates the absence of contribution to the total exposure. 
 
 Maximum levels deoxynivalenol, fumonisins, zearalenone 
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ABBREVIATIONS 
 
3-Ac-DON  3-acetyl-deoxynivalenol 
15-Ac-DON  15-acetyl-deoxynivalenol 
ARfD  Acute Reference Dose 
BMDL10  Lower 95 % confidence limit for a benchmark response of 10 % extra risk 
b.w.  Body weight 
CN  Combined Nomenclature 
CONTAM Panel  EFSA Scientific Panel on Contaminants in the Food Chain 
DON  Deoxynivalenol 
EC  European Commission 
EFSA  European Food Safety Authority 
ELISA  Enzyme-Linked Immunosorbent Assay 
FAO  Food and Agriculture Organization of the United Nations 
FUMO  Fumonisins 
HBGV  Health-Based Guidance Value 
HPLC  High Performance Liquid Chromatography 
IRTAC  Institut de Recherches Technologiques Agroalimentaires des Céréales 
JECFA  Joint FAO/WHO Expert Committee on Food Additives and Contaminants 
LB  Lower Bound 
LOD  Limit of Detection 
LOQ  Limit of Quantification 
MB  Middle Bound 
ML  Maximum Level 
NOAEL  No-Observed-Adverse-Effect Level 
NOEL  No-Observed-Effect Level 
PMTDI  Provisional Maximum Tolerable Daily Intake 
TDI  Tolerable Daily Intake 
tTDI  temporary Tolerable Daily Intake 
tML  temporary Maximum Level 
UB  Upper Bound 
UK  The United Kingdom 
UF  Uncertainty Factor 
WHO  World Health Organization 
ZON  Zearalenone 
 